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Anthrax, a fatal bacterial infection is caused by Bacillus anthracis, a gram-
positive, spore forming, capsulated, rod shaped organism. Centers for Disease Control 
(CDC) lists anthrax as Category A biological agent due to its severity of impact on 
human health, high mortality rate, acuteness of the disease and potential for delivery as a 
biological weapon. The currently available human vaccine in the United States (AVA 
anthrax vaccine adsorbed) is prepared from Alum adsorbed formalin treated supernatant 
culture of toxigenic, non-encapsulated strain of Bacillus anthracis with the principle 
component being protective antigen (PA83). Evaluation of anthrax vaccine given to 
nearly 400,000 US military personnel by Vaccine Adverse Event Reporting System 
(VAERS) showed adverse effects such as flu-like symptoms, local pain, large degree of 
inflammation, edema, malaise, rash, arthralgia, and headache following vaccination. All 
the adverse reactions are attributed to the composition of vaccine components. These 
vaccine preparations contain trace contaminants of lethal and edema factors that 
contribute to the adverse side effects. Also, the current method of vaccine manufacture 
has limited production capacity. 
The production of PA83, in plants through chloroplast genetic engineering might 
eliminate the concerns of adverse side effects and the levels of expression would ensure 
the availability of vaccine for the human population in an environmentally friendly 
approach. The primary concern is whether the PA83 purified from transgenic chloroplasts 
is as immunogenic as the PA83 in the AVA. For this, PA83 has been expressed in 
transgenic chloroplasts of Nicotiana tabacum var. petit Havana, by inserting the pag 
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(2205 bp) with the N-terminal 6X histidine tag, into the chloroplast genome by 
homologous recombination.  Chloroplast integration of the pag was confirmed by PCR 
and Southern analysis. The PA83 protein was detected in transgenic chloroplasts by 
immunoblot analysis using anti-PA83 antibodies. Maximum expression levels of PA83 
(14.17% TSP) were observed in mature leaves upon continuous illumination, due to the 
presence psbA 5’UTR, a light and developmentally regulated translation enhancer 
sequence. The PA83 has been purified by affinity chromatography using Ni resin 
columns. Chloroplast derived PA83 was functional in vitro and was able to lyse the 
mouse macrophages when combined with the lethal factor.  The in vitro assays showed 
that the crude extracts contained up to 20ug/ml of functional PA83.The immunization 
studies of PA83 on Balb/c mice, revealed highly immunogenic IgG titers. Subcutaneous 
immunization with purified chloroplast derived PA83 with adjuvant yielded IgG titers up 
to 1:320,000, similar to that of the group immunized with PA83 derived from Bacillus 
anthracis. Immunization of groups with PA83 combined with alhydrogel adjuvant 
showed four - eight times higher immune response than the groups without adjuvant. The 
higher expression levels of PA83 in transgenic chloroplasts might ensure the availability 
of anthrax vaccine to the general public and the high immune response observed in the 
mouse model would enable the replacement of the current AVA with a cleaner and safer 
vaccine. 
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INTRODUCTION 
Background and history of Anthrax 
 
Anthrax, a fatal bacterial infection is caused by Bacillus anthracis, a Gram-
positive spore-forming organism. It is a zoonotic disease transmitted from animals to 
humans. CDC lists anthrax as Category A biological agent due to its severity of impact 
on human health, high mortality rate, acuteness of disease and potential for delivery as a 
biological weapon. The disease is acquired when the spores enter the body either through 
the skin or inhalation or ingestion (Dixon et.al.,1999). Animals acquire infection while 
grazing on pastures contaminated with Bacillus spores. Humans acquire infection either 
when they come in contact with contaminated animals or affected humans. There are 
different forms of anthrax based on the route of infection. Cutaneous is anthrax the most 
common form, results from contact with contaminated animals or animal products. The 
cutaneous form can be treated with proper use of medication and is not fatal unless it 
becomes systemic. Inhalational anthrax, the fatal form results upon inhalation of spores. 
The mortality is almost 100% and death occurs usually within few days after appearance 
of symptoms. In the Inhalational form, systemic infection occurs with bacteremia and 
toxemia leading to shock and death. Gastrointestinal anthrax, often results due to 
consumption of contaminated food /feed with spores. The mortality is variable.  
Historically anthrax has been described in the fifth Egyptian plague (1500B.C.). 
Virgil, an ancient Roman poet recorded the description of anthrax in 25 B.C. This disease 
was popularly known as “Black Bane” in the middle ages. In 1870s Robert Koch 
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extensively studied Bacillus anthracis and demonstrated for the first time the bacterial 
origin of a specific disease (Pile et al., 1998). It served as the prototype for Koch’s 
postulates regarding the causation of infectious disease. The first vaccine containing 
attenuated live organisms was Louis Pasteur’s veterinary anthrax vaccine. In the 1900s, 
human inhalation anthrax occurred sporadically in the United States among textile and 
tanning workers. Eighteen cases of inhalational anthrax were reported in the United States 
from 1900 to 1976 (Inglesby et.al., 2002). An outbreak of inhalation anthrax occurred in 
Sverdlovsk near a Soviet military microbiology facility in 1979. This epidemic 
represented the largest documented outbreak of human inhalation anthrax in history 
(Sternbach, 2003). In October and November 2001, as a result of intentional release of 
the organism in the United States via US postal mail, 11 persons contracted pulmonary 
anthrax, and seven persons contacted the cutaneous form of the infection. Five of those 
with pulmonary anthrax died. (Inglesby et.al., 2002).  
The deliberate spread of anthrax spores through U.S.mail resulting in 5 deaths 
from inhalational anthrax has indicated the threat of anthrax being used as a biological 
weapon. The research on anthrax as a biological weapon began more than 80 years ago. 
In 1915, attempts were made by Germans to develop biological weapon using Bacillus 
anthracis spores. In 1937, Japan used B. anthracis as a biowarfare weapon against the 
Chinese. Other countries, specifically the USA, the UK, and the Soviet Union, also 
started developing B. anthracis as a weapon before and during World War II. More 
recently, Iraq has been implicated as having an active biological warfare program, 
utilizing a number of agents, including B. anthracis (Schmid and Kaufmann., 2002).B. 
anthracis has many biological, technical and virulence characteristics that make it 
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attractive as a bioweapon. B. anthracis is relatively easily obtained from a variety of 
sources. Once obtained, it is relatively easy to grow and process. The weaponized agent 
can be easily stored after production. It can be prepared with minimal technology, and, as 
the recent outrage has shown, it is easily delivered and engenders great public panic. 
When used as a weapon of mass destruction, the agent is dispersed in particles less than 
5µm in diameter, a size that allows penetration into the pulmonary alveoli. Aerosol 
dispersion can expose the greatest number of people over time (Oncu et.al., 2003). The 
World Health Organization estimated that 50 kg of weapon-grade anthrax spores released 
by an aircraft over an urban population of 5 million would result in 250,000 cases of 
predominantly inhalational anthrax. The economic impact was estimated at $26.2 billion 
per 100,000 persons exposed (Oncu et.al., 2003). This large scale mass destruction 
creates the need for large scale prophylactic measures involving production and 
stockpiling of vaccines and drugs that counteract the infection. 
Bacillus anthracis is gram positive, anaerobic, capsulated, sporulating, rod shaped 
bacteria. The virulent strains of B. antharcis carry plasmids pX01 that carries genes 
encoding the toxins and pX02 that encodes for the poly-D-glutamic acid capsule 
(Brossier and Mock., 2001).  PX01 carries the genes pagA, lef and cya that encode for 
protective antigen, lethal factor (LF) and edema factor (EF) respectively. The term 
protective antigen is derived because of its ability to elicit a protective immune response 
against anthrax. None of these proteins are toxins individually. However, the protective 
antigen in combination with edema factor, known as edema toxin causes edema. 
Similarly the protective antigen in combination with lethal factor forms lethal toxin 
(Welkos et.al., 1998, Mogridge et.al., 2001). The ORF of the protective antigen gene 
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(pag) is 2319 bp long of which 2205 bp encode 735 amino acids of the mature protein 
(PA83). This region is preceded by 29 codons, which encode signal peptide (Welkos 
et.al., 1988.) The monomer is organized mainly into anti-parallel beta-sheets and has four 
domains. Domain 1(residues 1-249) is an amino-terminal domain containing two calcium 
ions and the cleavage site for activating proteases; Domain 2 (residues 250-487) a 
heptamerization domain, contains a large flexible loop implicated in membrane insertion; 
Domain 3 (residues 488-594) is a small domain which has the hydrophobic patch that is 
thought to be implicated in protein protein interaction; and Domain 4 (Residues 595-735) 
is a carboxy-terminal receptor-binding domain. The Protective antigen binds to the 
anthrax toxin receptor (ATR), a membrane protein. (Bradley et.al., 2001). Once the 
carboxy-terminal of PA binds to the ATR, it is cleaved into two fragments by furin 
family of cell-associated proteases. Removal of a 20K amino-terminal fragment from 
domain 1 allows the PA63 fragment bound to the anthrax toxin receptor (ATR) and 
exposes a hydrophobic surface for binding the toxic enzymes, EF and LF (Petosa et al., 
1997, Brosssier and mock, 2001, Mogridge et al., 2002). This interaction is via amino 
terminal domains of EF and LF (Mogridge et al., 2002). Each of the toxic enzymes 
exhibits competitive binding for PA (Gupta et al., 1999.)  . The PA63 forms an assembly 
of the heptamer, a ring-shaped structure with a negatively charged lumen, and exposes 
the hydrophobic surface (Petosa et al., 1997, Brosssier and Mock, 2001, Mogridge et al., 
2002). After the toxin components bind to the hydrophobic surface of PA63, the 
hepatamer gets internalized by receptor mediated endocytosis into the lumen of 
endosomes where PA63 is believed to interact with the endosomal membrane, forming a 
channel to facilitate the translocation of EF and LF across the lipid bilayer into the 
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cytosol (Jill et al., 1994, Milne et al., 1994). Proteolytic cleavage of PA83 to PA63 and 
the low acidic pH in the endosome is required for the membrane insertion and channel 
formation (Milne et al., 1994). LF is a highly specific, four-domain zinc metalloprotease 
that cleaves members of the MAPKK family within their N-termini. This cleavage 
initiates a poorly characterized chain of events leading to host death (Inglesby, 1999). A 
rapid and selective apoptosis of lipopolysaccharide-activated macrophages has been 
correlated to the LF-induced cleavage of the N-terminal portion of MAPKKs with 
activation of the p38 mitogen-activated protein kinase (MAPK) (Ascenzi et al., 2002). By 
inducing apoptosis of activated macrophages, LT could prevent the release of 
chemokines and cytokines that alert the immune system to the presence of infecting B. 
anthracis, thereby facilitating the systemic spread of the infection. The final stages of 
anthrax have all the characteristics of a septic shock triggered by an extensive release of 
vasoactive mediators of inflammation. Perhaps LF also cleaves other intracellular 
substrates or it exhibits additional functions in host cells, which could account for these 
pathophysiological observations (Chaudry et al., 2002). EF is a calcium- and CaM-
dependent adenylyl cyclase that takes ATP, separates two phosphates and forms cAMP. 
EF saturates the cell with cAMP, disturbing water homeostasis and destroying the 
delicate balance of intracellular signaling pathways. Moreover, EF impairs neutrophil 
functions and is believed to be responsible for the edema found in cutaneous anthrax ( 
Acenzi et al., 2002). 
Protective antigen is a primary immunogen and is a component of human 
vaccines in UK and USA. The currently available human vaccines in the United States 
and Europe are prepared from Alum adsorbed formalin treated supernatant culture of 
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toxigenic, non-encapsulated strain of Bacillus anthracis. Bioport Corp, Lansing, 
Michigan, produces the anthrax vaccine in USA. The anthrax vaccine adsorbed (AVA) is 
licensed in 1970 to be given to all US military active and reserve duty personnel 
(Inglesby et al., 1999). The introduction of the adsorbed anthrax vaccine was followed by 
a substantial decrease in cases of anthrax among workers in the wool and leather 
industries, and the disease has become rare in the United Kingdom (Hambleton et al., 
1984). Data from a 1950s trial of wool-sorters immunized with a vaccine similar to AVA, 
coupled with long experience with AVA and the United Kingdom vaccine have shown 
that a critical level of serum antibodies to the B. anthracis PA confers immunity to 
anthrax (Leppla et al., 2002, Pittman et al., 2000). Although PA in AVA evokes the 
protective immune response, AVA has limitations that justify the widespread interest in 
developing improved vaccines consisting solely of well-characterized components, this 
vaccine contains other cellular elements that contribute to the relatively high rate of local 
and systemic reactions. To assess the safety of a licensed anthrax vaccine given to nearly 
400,000 US military personnel, reports of adverse events submitted to the Vaccine 
Adverse Event Reporting System (VAERS) were reviewed and evaluated medically. The 
Anthrax Vaccine Expert Committee (AVEC), reviewed 602 VAERS reports to assess the 
causal relationship between vaccination and the reported adverse effects and sought to 
identify unexpected patterns in the occurrence of medically important events. Nearly half 
the reports noted a local injection-site, with more than one-third of these involving a 
moderate to large degree of inflammation. Six events qualified as serious adverse effects, 
and all were judged to be certain consequences of vaccination. Three-quarters of the 
reports cited a systemic adverse effects (most common: flu-like symptoms, malaise, rash, 
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arthralgia, headache). (Sever et al., 2002). Geier and Geier, 2002 have conducted an 
analysis to evaluate anthrax vaccine (AVA) and joint related adverse reactions based 
upon analysis of the VAERS database. The analysis shows a very large and statistically 
significant increase in joint symptoms following vaccination with AVA when compared 
to our control population consisting of adverse joint reactions reported following 
vaccination with hepatitis A vaccine and Td vaccine (Geier and Geier, 2002). All these 
adverse reactions are attributed to the substandard levels of vaccine production and the 
composition of vaccine components. The anthrax vaccine is produced by the Health 
Protection Agency (HPA, Porton Down, UK, Product Licence 1511/0058), and by 
Bioport Inc. (Lansing, Michigan, US Licence 99). The British anthrax vaccine is 
produced from supernatant of a static culture of the Sterne strain, a non-encapsulated 
toxigenic variant of B. anthracis, which is filtered through a 0.2 µm filter and adsorbed to 
aluminium salts after precipitation with alum (Hambelton et al., 1984, Turnbill, 1991, 
Whiting et al., 2004). The precipitate contains PA, and it is claimed that the filter 
selectively retains some of the enzymatic components of the anthrax toxin, EF and LF 
(Hambelton et al., 1984). The American anthrax vaccine is made from a cell-free filtrate 
of a fermentor culture of nonencapsulated toxigenic strain V770-NP1-R. Aluminium 
hydroxide is added to precipitate antigens from the cell free supernatant. The precipitate 
contains predominantly PA, small quantities of LF and trace amounts of EF (Ivins et al 
.,1998, Whiting et al., 2004). Serological studies of vaccinated humans and vaccinated 
guinea pigs suggested that the British vaccine contains more EF and LF and less PA than 
the American vaccine (Turnbill, 1991). Whiting et al recently performed two-
dimensional gel electrophoresis to define the protein components of the current UK 
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anthrax vaccine. It was demonstrated that the major antigen present in the vaccine is PA. 
The 83 and 63 kDa species are dominant but there are numerous lower molecular weight 
fragments resulting from proteolytic cleavage. Besides PA, the presence of the toxin 
components, edema factor and lethal factor, and S-layer proteins, EA1 was also 
demonstrated. Mass spectrometry has also revealed the presence of several bacterial cell-
derived proteins present in the vaccine, including PA, enolase, fructose-bisphosphate 
aldolase, nucleoside diphosphate kinase and a 60 kDa heat shock protein (Whiting et al., 
2004). These vaccine preparations contains traces of lethal and edema factors that 
contribute to the side effects such as local pain and edema (Leppla, 2002). Also, the 
current vaccine supplies are limited. It will take years before increased production efforts 
can make available sufficient quantities of vaccine for civilian use. (Inglesby et al., 
1999). Therefore, an effective expression system that can provide a clean and safe 
vaccine is required. 
 
Chloroplast genetic engineering 
 
The concept of chloroplast genetic engineering was first conceived in the mid 80s 
with the introduction of isolated intact chloroplasts into protoplasts (Daniell and Dhingra, 
2002). Later focus was laid on the development of chloroplast systems capable of 
efficient, prolonged protein synthesis and the expression of foreign genes (Daniell and 
McFadden, 1987). Transformation using biolistics has made it feasible to transform 
plastids without the need to isolate them (Klein et al., 1987). In 1998, the first successful 
chloroplast genome complementation was reported for the unicellular green alga having 
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single chloroplast, Chlamydomonas reinhardtii (Boynton et al., 1988). For this, the 
photosynthetically incompetent mutants that lacked atpB gene were used. These mutants 
lacked chloroplast ATP synthase activity. The wild-type atpB gene was introduced into 
the cells using tungsten microprojectiles coated with atp gene (Klein et al., 1987). The 
single large chloroplast provided an ideal target for DNA delivery. The wild-type atpB 
gene introduced into cells was able to correct the deletion mutant phenotype which was 
demonstrated by the restoration of photoautotrophic growth upon selection in the light. 
This proved that the wild-type gene carried by the vector was successfully integrated into 
the C. reinhardtii chloroplast genome via homologous recombination, replacing the 
deleted atpB gene. Later, using the uidA gene, it was then demonstrated that the foreign 
DNA flanked by chloroplast DNA sequences is incorporated and stably maintained in the 
C. reinhardtii chloroplast genome; although the introduced uidA gene was transcribed, 
translated product could not be detected (Blowers et al., 1989).  After the successful 
transformation of the unicellular algae C. reinhardtii through chloroplast genome, efforts 
were made to transform the higher plants through chloroplast genome.  Initially in higher 
plants, foreign genes were introduced and expressed only in isolated but intact plastids 
(Daniell and McFadden, 1987). The first transient expression of a foreign gene in plastids 
of cultured tobacco cells used autonomously replicating chloroplast vectors (Daniell et 
al., 1990). This work was repeated in wheat leaves, calli and somatic embryos (Daniell et 
al., 1991). Simultaneously, the C. reinhardtii chloroplast genome was transformed with 
the aadA gene conferring spectinomycin or streptomycin resistance (Goldschmidt-
Clermont, 1991); This became a major breakthrough because the majority of higher 
plants genetically transformed via the chloroplast genome now use aadA gene as 
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selectable marker. Stable integration of the aadA gene into the tobacco chloroplast 
genome was then demonstrated (Svab and Maliga, 1993). Initially, when the transgenes 
were introduced via the chloroplast genome, it was believed that foreign genes could be 
inserted only into transcriptionally silent spacer regions within the chloroplast genome 
(Zoubenko et al, 1994). However, (Daniell et al.1998) advanced forwarded the concept 
of inserting transgenes into functional operons and transcriptionally active spacer regions. 
This approach facilitated the insertion of multiple genes under the control of a single 
promoter, enabling the coordinated expression of transgenes (Daniell and Dhingra, 2002). 
Chloroplast genetic engineering technology is currently applied to other useful crops such 
as potato, tomato, carrot, cotton and soybean by transforming the plastids (Sidorov et al., 
1999; Ruf et al., 2001; Kumar et al., 2004a, Kumar et al., 2004b, Dufourmantel et al., 
2004). 
  Tobacco, a non-food/ feed crop is proven to be ideal for transformation because of 
its ease for genetic manipulation. Tobacco is an excellent biomass producer (in excess of 
40 tons fresh leaf weight/acre based on multiple mowings per season) and a prolific seed 
producer (up to one million seeds produced per plant), which is ideal for the large-scale 
commercial production. It has been extensively used for the large-scale production of 
therapeutic proteins production. It has been estimated that the cost of production of 
recombinant proteins in tobacco leaves will be 50-fold lower than that of Escherichia coli 
fermentation systems (Kusnadi, 1997). Using the chloroplast transformation, tobacco has 
been used for hyper-expression of vaccine antigens and production of valuable 
therapeutic proteins like human elastin-derived polymers for various biomedical 
applications (Guda et al., 2000), vaccines antigens for cholera (Daniell et al., 2001a), 
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monoclonal antibody. Guy’s 13, a monoclonal antibody against Streptococcus mutans to 
protect against dental carries, have also been expressed in the chloroplast (Daniell et al., 
2001b). Human therapeutic proteins, including human serum albumin (Fernandez et al; 
2003), magainin, a broad spectrum topical agent, systemic antibiotic, wound healing 
stimulant and a potential anticancer agent (Degray et al; 2001), interferon (Daniell et al; 
2004a) and insulin- like growth factor (Daniell, 2004) have been expressed. Several other 
laboratories have expressed other therapeutic proteins, including human somatotropin 
(Staub et al; 2000) and interferon-GUS fusion proteins (Leelavathi and Reddy, 2003) in 
transgenic chloroplasts.  
The chloroplast transformation technology has been used to introduce the various 
agronomic traits. Insect resistance has been achieved by expressing insecticidal proteins 
from Bacillus thuringiensis (Bt); the Cry2Aa2 protein had accumulated up to 46.1% tsp 
and this is by far the highest expressed foreign protein in transgenic plants to date. 
(DeCosa et al., 2001). Similarly herbicide resistance against Glyphosate, a broad-
spectrum herbicide that non-selectively kills the weeds by inhibiting the 5-
enolpyruvylshikimate- 3-phosphate synthase (EPSPS), a nuclear-encoded chloroplast-
localized enzyme in the shikimic acid pathway of plants and microorganisms that is 
required for the biosynthesis of aromatic amino acids.  The plastid that was engineered 
with EPSPS gene in tobacco plants developed resistance to glyphosate over the wild type 
plants (Daniell et al., 1998). The antimicrobial peptide MSI-99, an analog of magainin 
has been expressed in the chloroplast genome of transgenic tobacco upto 21.5% TSP (De 
gray et al., 2001). MSI-99, offers protection against prokaryotic organisms due to its high 
specificity for negatively charged phospholipids found mostly in bacteria. Extracts from 
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MSI-99 transformed plants inhibited growth of Pseudomonas aeruginosa, a multi-drug 
resistant bacteria, which acts as an opportunistic pathogen in plants, animals, and 
humans.  It is also biologically active against Pseudomonas syringae, a major plant 
pathogen. (DeGray et al. 2001, Devine and Daniell, 2004, Daniell et al., 2004a).  The 
yeast trehalose phosphate synthase (TSP1) gene expressed in the chloroplast showed a 
high degree of drought tolerance (Lee et al., 2003).  The Daniell lab recently engineered 
the carrot plastid genome with the BADH gene, which conferred tolerance to salt (Kumar 
et al., 2004a).  
 
Vaccine antigens Expressed Via the Chloroplast Genome 
 
Expressing vaccine antigens via the chloroplast genome has proven to be 
advantageous: subunit vaccines which do not express active toxins are safe and do not 
multiply; bacterial genes have high AT content allowing for high expression in the 
chloroplast; and oral delivery of vaccines yields high mucosal IgA titers along with high 
systemic IgG titers, enabling the immune system to fight against germs at portals of 
entry. Vaccines that have already been expressed in the chloroplast include the C 
terminus of Clostridium tetani (TetC) (Maliga P, 2003), the Cholera toxin B-subunit 
(CTB), which does not contain the toxic component that is in CTA (Daniell et al. 2001a), 
the 2L21 peptide from the Canine Parvovirus (CPV) (Molina  et al., 2004) and the F1~V 
fusion antigen for plague (Singleton et al., 2003).CTB was expressed at 4 to 31% of Total 
Soluble Protein (TSP) and was effective in the GM1-ganglioside binding assay which 
indicates proper folding and formation of disulfide bonds to form pentamers (Daniell  et 
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al. 2001a, Molina et al., 2004).  The C terminus of Clostridium tetani (TetC) was 
expressed at 25% TSP for AT rich and 10% TSP for GC rich sequences which shows that 
chloroplasts favor prokaryotic-AT rich sequences.  TetC when administered intranasally, 
produced both IgG and IgA and was immunoprotective against the toxin (Tregoning et 
al., 2003).  The 2L21 peptide from the Canine Parvovirus (CPV) fused to GFP expressed 
22% TSP and CPV fused to CTB 31% TSP (Molina  et al., 2004). When mice were 
immunized intraperitoneally with the leaf extracts from CTB-2L21, the developed anti-
2L21 antibodies able to recognize VP2 protein from CPV. To date, only two vaccine 
candidates derived from chloroplast genetic engineering have been tested for 
immunogenecity in mice and only one vaccine candidate has been tested for 
immunoprotective property. High expression is not only economically important, but for 
oral vaccines it is essential for the immune response. 
 
Bioencapsulation for the oral delivery of vaccine antigens and protection of 
immunogens in the Gut 
 
Bioencapsulation of pharmaceutical proteins within plant cells offers protection 
against digestion in the stomach yet allows for successful delivery (Walmsley and 
Arntzen, 2000; Yu and Langridge, 2001). In human clinical trials performed with plant 
derived vaccines, plant cells have proven sufficient for vaccinogen protection against 
digestion, and the vaccinogen has induced systemic and mucosal immune responses 
without the aid of adjuvants (Tacket et al., 1998, Kapusta et al., 1999, Tacket et al., 
2000,Walmsley and Arntzen, 2000,Tacket et al., 2003 Tacket et al., 2004). Heat-labile 
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enterotoxin B-subunit (LTB) from E. coli was expressed by nuclear transformation in 
tobacco (<0.01% Total soluble protein) and potato (0.19% TSP).  The LTB expressed in 
potato was found to be immunoprotective when administered orally.  Inspite of lower 
expression in tobacco these antigens were immunogenic (Haq et al., 1995, Mason et al., 
1996, Tacket et al., 1998).  The capsid protein of the Norwalk virus expressed in potato 
and tomato was immunogenic when administered orally (Mason et al., 1996, and Richter 
et al., 2000, Tacket et al., 2000).  The envelope surface protein of hepatitis B virus was 
expressed by nuclear transformation in tobacco, potato and lupin.  They all had less than 
0.01% fresh weight expression but were still immunogenic (not protective) when 
administered orally (Richer et al., 2000, Kapusta et al., 1999). This again brings us to the 
need to ensure high expression of therapeutic proteins in plants.  IFN-alpha given orally 
has biologically activity in humans and other animals (Bocci 1999). Plant derived edible 
vaccines have also proven in commercial animal and native animal trials (Castanon et al., 
2000, Tuboly et al., 2000).  Bioencapsulation is therefore protecting these antigens or 
therapeutic proteins from digestion so that they remain biologically active. Chloroplast 
genetic engineering is currently being applied to crops amiable to oral vaccines such as 
potato, tomato, carrot and soybean (Sidorov et al., 1999, Ruf et al., 2001, Kumar et al, 
2004a, Dufourmantel et al., 2004).   
 
Advantages of Chloroplast Expression Over Expression in E. coli 
 
Chloroplast expression system has several advantages over E. coli expression 
system.  Production of recombinant proteins in microorganisms is expensive, requires 
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stringent purification protocols, and scale-up requires building costly fermenters.  
Vaccine production in plants can circumvent these problems. First, farming of plants is 
straightforward, fairly inexpensive, and can be scaled-up at low cost in one season.  The 
cost of production of recombinant proteins in tobacco leaves will be 10 to 50 times 
cheaper than that of E. coli fermentation (with 20% expression levels in E. coli, Kusnadi 
et al., 1997). 
Second, plants provide a heat-stable environment for proteins, and the technology 
already exists for harvesting, storage, and purification of transgenic plant proteins.  In 
addition, each transgenic plant generated can produce up to a million seeds per plant . 
Third, the use of plants to produce vaccines eliminates the threat of other 
components of B. anthracis from entering the vaccine.  It also avoids contamination with 
animal pathogens.   
Fourth, chloroplasts are capable of folding proteins and maintaining their natural 
conformation.  Folding, assembly and production of disulfide bridges for CTB has 
already been demonstrated in chloroplasts (Daniell 2001a). Binding assays proved that 
chloroplast synthesized CTB binds to the GM-1 ganglioside receptor.  Many antigens for 
vaccines that have been expressed in chloroplasts have been proven to be immunogenic 
(Tregoning  et al., 2003, Molina et al., 2004).    
Lastly, the process of purification of a recombinant protein produced in E. coli is 
costly and time consuming.  For example, for insulin production, chromatography 
accounts for 30% of the production cost and 70% of the set-up cost (Petrides et al. 1995).  
A transformed tobacco plant would still need purification.  But an edible vaccine such as 
in the carrot or tomato would eliminate this cost.  Expenses for delivery by injection 
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would also be eliminated.  Therefore, expression of PA in the carrot plastids for oral 
vaccination would be beneficial. The transgenic chloroplast derived PA will have to be 
tested to prove its functionality invivo. This work would pave the way for the oral 
delivery vaccine in carrot. 
 
Advantages of Chloroplast Transformation Over Nuclear Transformation 
 
Cross Pollination with pollen from Genetically Modified crops with the wild type 
crops is a major concern. However, by genetically engineering the chloroplasts, the 
possibility of cross-pollination with pollen carrying transgenes is eliminated because 
chloroplasts DNA are maternally inherited.  Although pollen from plants was shown to 
exhibit maternal plastid inheritance through metabolically active plastids, the plastid 
DNA itself is lost during the process of pollen maturation and hence is not transmitted to 
the next generation. During fertilization, the paternal chloroplasts from pollen are 
disintegrated in a synergid cell and only the sperm nucleus enters the egg cell and fuses 
with the egg to form a zygote.  Maternal inheritance thus offers the advantage 
containment of chloroplast transgenes due to lack of gene flow through pollen (Daniell, 
2002, Daniell and Parkinson, 2003). The transgene inheritance thus occurs only via seeds. 
This environmental eco-friendly feature should eliminate all the concerns of cross 
contamination with wild type and relative crops.  
In order for plant production of proteins to be commercially feasible, expression 
levels greater than 1 % of the total soluble protein must be achieved in plants (Kunsnadi 
et al., 1997).  Nuclear transformation of plants has usually produced lower expression 
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levels of antigens (Daniell et al., 2001a, May et al., 1996, Richter et al., 2000, Tacket et 
al., 2000, Ramirez et al., 2003, Devine and Daniell, 2004, Daniell et al., 2004b, Daniell 
et al., 2004c).  For example, plant derived recombinant hepatitis B surface antigen was as 
effective as a commercial recombinant vaccine, but the levels of expression in transgenic 
tobacco were low (0.0066% of total soluble protein).   
For an oral delivery vaccine, it may prove to be extremely important to have high 
expression levels in order to elicit the immune response. An alternative approach to 
nuclear transformation is to integrate foreign genes into the chloroplast genome, which is 
a powerful technique because of the number of copies of chloroplast genomes per cell up 
to 10,000). This high polyploidy leads to high transcript levels and finally accumulation 
of abundant translated product resulting in high expression levels upto 47% of (DeCosa 
et al., 2001).   
Chloroplast transformation occurs exclusively through site-specific homologous 
recombination.  In contrast, nuclear transformation experiments frequently suffer from 
gene-silencing mechanisms resulting in unstable and inconsistent gene expression or 
complete loss of transgenic activity. The nuclear genome has mechanisms that may 
inactivate genes when regulatory sequences are inserted in a repetitive pattern. This 
occurs because integration of transgenes into the nuclear genome is random and not via 
homologous recombination (Daniell and Dhingra, 2002).  This random integration of 
transgenes may allow for insertion of the transgene into a region of the nuclear genome 
that is not highly transcribed. Due to the random position of the transgene in the nuclear 
genome, expression levels vary in different transgenic lines. However, neither gene 
silencing nor position effects have been observed in genetically engineered chloroplasts 
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(Daniell, and Dhingra, 2002). Chloroplast transgenic lines with accumulation of 
transcripts 169-fold higher than nuclear transgenic lines have shown no gene silencing 
(Lee et al., 2003, Dhingra et al., 2004).  Likewise, chloroplast transgenic lines showed no 
transgene silencing at the translational level regardless of accumulation of foreign protein 
up to 47% TSP (DeCosa et al., 2001). Besides, the chloroplast genetic engineering offers 
attractive advantages of introducing multigenes in a single transformation step because of 
its ability to transcribe the operon with multigenes into polycistronic mRNA and translate 
the polycistronic mRNA. This saves a lot of time to create a transgenic plant expressing 
multigenes as opposed to the nuclear transformation where several independent 
transgenic lines have to be created followed by the laborious repetitive breeding. 
(DeCosa et al., 2001, Ruiz et al., 2003, Daniell and Dhingra, 2002, Lossl et al., 2003). 
 
Advantages of Producing the Anthrax Vaccine in Plant Plastids 
 
1. There are no known human or animal pathogens that affect plants (Streatfield et al., 
2001), production of PA83/PA63 protein in plants would yield a vaccine free of human 
pathogens. 
2. The PA antigen genes have an A/T content of 67%, which are ideal for chloroplast 
expression of these proteins.  Because chloroplasts are prokaryotic in nature they tend to 
exhibit higher expression with higher AT content genes. 
3. Bacterial proteins have been expressed at extraordinarily high levels in transgenic 
chloroplasts.  This includes AT rich proteins such as Cry2a (67% AT) at 47% Total 
Soluble Protein (DeCosa et al., 2001, CTB (59% AT) at 33% TSP (Daniell et al., 2001a), 
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and Human Serum Albumin (66% AT) up to 11.1% TSP, (Fernandez-San Millan et al., 
2003).  Disulfide bonds in the above examples were properly formed. 
4. The PA antigen is not glycosylated, which is good for our particular system because 
plastids do not glycosylate proteins.  
5. The technology to sow, harvest, store, and transport crops already exists.  
6. Plants have up to 100 chloroplasts per cell, each containing about 100 chloroplast 
genomes.  This provides up to 10,000 genomes per cell to efficiently produce the antigens 
7. Using the chloroplasts eliminates cross-pollination of the transgene by pollen because 
chloroplast’s DNA is maternally inherited (Daniell, 2002, Daniell and Parkinson, 2003). 
8. Transgene integration is specifically targeted to intergenic spacer sites in the chloroplast 
genome; this eliminates gene silencing and the position effect that is seen in nuclear 
transformation (Daniell et al., 2002; Daniell and Dhingra, 2002). 
9. AT rich CTB has been produced in transgenic chloroplasts in our lab and has been shown 
to have native conformation via the GM1-ganglioside binding assay.  It was produced 410 
and 3100-fold higher in transgenic chloroplasts than nuclear transgenic plants at 4.1 and 
31% total soluble protein (Daniell et al. 2001a, Monila et al., 2004).   
10. Vaccine antigens have already been expressed in plants and have shown to be protected 
in the stomach through bioencapsulation.  Also, they have been proven immunogenic 
when administered orally in clinical trials (Tacket et al., 1998, kapusta et al., 1999, 
Tacket et al., 2000, Castanon et al., 2000, Tuboly et al., 2000, Walmsley and Arntzen, 
2000,Tacket et al., 2003 Tacket et al., 2004).   
11. Using plastid transformation technology, large quantities of vaccine can be produced. 
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12. Proving that this vaccine is immunogenic when produced in tobacco chloroplasts could 
justify the expense to engineer oral vaccines by transforming plastids of carrot and 
tomato. Delivery of plant-derived vaccine to mucosal tissues has been proven to induce 
both a mucosal and a systemic immune response (Haq et al.1995., Mason et al.1996, 
Arakawa et al., 1998).  Mucosal immunization may give higher protection from 
aerosolized spores of anthrax by producing s-IgA in the mucosal system. 
 
Rationale and Approach 
 
The objective of the project is to evaluate if chloroplast derived PA83 is 
immunogenic in the mouse model. If so, evaluate the immunogenicity of the chloroplast 
expressed PA83 relative to the PA83 derived from Bacillus anthracis. To evaluate the 
imunogencity, experiments were planned to observe the efficacy of purified chloroplast 
derived PA83 with that of PA83 obtained from Bacillus anthracis. In order to obtain the 
purified chloroplast derived PA83, the purification methods for plant proteins were 
analyzed to determine the most optimal one. The Affinity chromatography using Ni resin 
column appeared to be the most feasible with single step purification.  For this the 
transgenic lines had to be obtained that express full length PA83 with his-tag that would 
aid in easy, efficient and economical method of purification. Observing the chain of 
events that occur from binding of PA83 to anthrax toxin receptor to the translocation of 
EF and LF by PA, it appeared that the cleavage of PA83 to the PA63 on the anthrax toxin 
receptor is the rate-limiting step in the down stream sequence of events. Therefore, we 
decided to express PA63 with his-tag so that the rate-limiting step can be overcome 
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eliminating the N-terminal 20kDa protein and observe how functional potency of PA63 
would differ from PA63. The strategic approach is to introduce 6X histidine N-terminal 
to pag by performing polymerase chain reaction using primers as described in Materials 
and Methods section. Protein isolation and purification from plants is a difficult task, due 
to the complexity of the plant system compared to bacterial or yeast systems (Desai et al., 
2002). The better yield of the protein PA83 can be obtained by reducing the purification 
steps. So the use of single step affinity chromatography would lower the loss of PA83 
during purification steps. 6X histidine engineered at N-terminal of PA83 will aid in 
purification process. The PsbA 5’UTR which is a transcription and translation enhancer 
will be placed upstream of pag to enhance translation. (Fernandez-San Millan et al., 
2003, Dhingra et al., 2004). The expressed protein will be purified using affinity 
chromatography. The purified protein PA83 will be evaluated for immunogencity on the 
mouse system. The immunogenicity will be evaluated under different parameters. These 
include the immuogenicity of chloroplast derived PA relative to PA derived from 
Bacillus anthracis when administered subcutaneously; with or without adjuvant, in the 
purified and crude form. If appropriate results are achieved, the mice will be challenged 
with the toxin to observe the survival rate. If chloroplast derived PA functions 
effectively, it can be proposed for the human clinical trials to replace the current PA. This 
work will encourage the plastid transformation of carrots for the oral delivery of anthrax 
vaccine. 
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MATERIALS AND METHODS 
General protocols 
Preparation of Ultra competent cells (Rubidium Chloride Method) 
   
The ultra competent cells were prepared using rubidium chloride method 
(http://www.nwfsc.noaa.gov/protocols-/rbcl.html). The ultra competent cells are 
absolutely necessary for the transformation of bacterial cells with the plasmid. E. coli 
XL1-Blue MRFab (Stratagene), a disabled non pathogenic, tetracycline resistant strain, 
has a history of safe laboratory use due to its inability to survive in the environment has 
been used to prepare the ultra competent cells. The E.coli glycerol stock was streaked on 
the LB agar plate containing 12.5 µg/ml  tetracycline and incubated at 37°C overnight. 
Single isolated colony was picked and grown in 5 ml of Psi broth containing 12.5 µg/ml 
tetracycline and incubated at 37°C for 12- 16 hrs in a horizontal shaker at 225 rpm. 
Approx. 1 ml of the overnight culture was inoculated in 100 ml of Psi broth and was 
incubated at 37°C for about 2 hours in a shaker at 225 rpm. The optical density (O.D) 
was checked at 550 nm after two hours and subsequently after each half hour or an hour 
depending on the O.D value.  The culture was continued to grow until it reaches to 0.48 
O.D.  The culture was kept on ice for 15 minutes.  The cells were pelleted by 
centrifugation at 3000g/5000 rpm for 5 minutes in a sorvall centrifuge.  The supernatant 
was discarded and the pellet was resuspended in 0.4 volume (40 ml) of ice cold TFB-I 
solution. The cells were re-pelleted at 3000g/ 5000 rpm for 5 minutes.  The supernatant 
was discarded and the cells were resuspended in (0.04 volume) 4 ml of TFB-II solution 
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and immediately iced for 15 minutes.  This suspension was divided into 100 µl aliquots 
then quick freezed in dry ice/liquid nitrogen and stored at - 80°C. 
Transformation of the Competent E. coli XL1-Blue cells 
 
 The competent cells of one hundred µl aliquot were taken from -80°C and 
immediately thawed on ice and transferred to a falcon tube. About one µl (100 ng) 
plasmid DNA was added to the competent cells and was mixed by gentle tapping.  The 
mixture was incubated on ice for 30 minutes with gentle tapping at after first 15 min.  
Then the mixture was incubated at 42°C in a water bath for 90-120 seconds then 
immediately put on ice for two minutes.  Approx. 900µl of LB broth was added to cells 
and were incubated at 37oC for 45 minutes in a horizontal shaker at 225 rpm.  The cells 
were pelleted by spinning at 13,000 rpm for 30 seconds.  The nine hundred µl of 
supernatant was discarded leaving 100µl, followed by resuspending the cells.  Two 
samples, 50µl and 100µl, of the suspension were inoculated on the agar plate with 
appropriate selection agent and spread with a glass rod. (http://www.nwfsc.noaa.-
gov/protocols-/rbcl.html)  
Isolation of Plasmid DNA by Alkaline lysis 
 
A Single isolated colony was picked from the LB agar plate and was grown in LB 
medium for 12-16 hours at 37°C in a shaker at 225rpm. 1.5 ml of the cells were put into 
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an eppendorf tube and centrifuged at 13,000 rpm for 1 minute. The supernatant was 
discarded and  the pellet was resuspended in 150 µl of Solution I (GTE: 50 mM Glucose, 
10 mM EDTA, 25 mM Tris, pH- 8) and the mixture was vortexed to resuspend the cells. 
One µl of RNase (100 mg/ml) was added to each tube and pulse vortexed.  One hundred 
fifty µl of Solution II (0.2N NaOH, 10% SDS) was added to each tube and mixed by 
gently inverting the tube 6 times. Further, one hundred fifty µl of Solution III (60 ml of 
5M Potassium Acetate, 11.5 M glacial acetic acid, 28.5 ml sterile dH2O) was added and 
mixed by gentle inverting 6 times.  The mixture was centrifuged at 13,000 rpm for 10 
minutes at 4°C. The supernatant was transferred into a fresh, eppendorf tube taking care 
to exclude white debris (which is bacterial chromosomal DNA/SDS/membrane proteins). 
Then 900 µl of ice cold, ethanol (95%) was added to the supernatant and to precipitate 
the plasmid DNA. The supernatant was centrifuged at 13,000 rpm at 4°C for 10 minutes. 
The supernatant was removed and discarded, taking care not to dislodge the plasmid 
DNA pellet in the bottom. To remove the salts from DNA, 400µl of 70 % chilled ethanol 
was added and (without mixing) centrifuged for 5 minutes. The ethanol was discarded 
and the pellet was subsequently dried in the speedvac on medium heat for 3-5 minutes.  
Dried DNA pellet was resuspended in TE (pH 8.0). Concentration and quality plasmid of 
DNA was measured by spectrophotometer.  DNA was stored at -20°C.  The DNA 
samples were run on a 0.8% agarose gel for 40 minutes at 80 volts to confirm the 




Construction for pLD-5’UTR-HisPA83 vector for transformation of tobacco 
Chloroplast 
 
Polymerase Chain Reaction was performed to introduce a 6X Histidine tag and 
Factor Xa protease cleavage site N-terminal to pag using primers forward 5’ –
ACGGTTTCCCCATATGCACCATCATCATCATCATTCTTCTGGTATAGATGGAA
GAGAAGTTAAACAGGAG- 3’ and reverse 5’-CTGATTTTGTTAGCTCGAGA-
AGCTTTATTAATCAC- 3’ (Invitrogen). The plasmid p-Blue script-gene10-pag (PA83 
gene) was used as the template and PCR amplified product of size approx. 370 bp 
containing Nde I restriction site at the 5’end and Xho I restriction site at the 3’ end was 
obtained. For a 50 µl reaction volume, the PCR was set as follows: 100ng of plasmid 
DNA, 5 µl of 10X pfu buffer, 5µl of 2.5 mM dNTP, 1µl of each 10mM primer, 0.5µl pfu 
DNA polymerase and H2O to make up the final volume. The PCR amplification was 
carried for 25 cycles as following: 94°C for 45 sec, 65°C for 45sec, and 72°C for 45sec 
for the. Cycles were preceded by denaturation for 5 min at 94°C and followed by a final 
extension for 7 min at 72°C. The 5µl of each PCR products including the contorls were 
loaded into a 0.8% gel to analyse the PCR product.  The PCR product was purified using 
PCR purification kit (Qiagen). The phosphate groups were added to the PCR fragment to 
the 5’ ends of both strands and cloned into EcoRV digested and dephosphorylated p-Blue 
script plasmid vector. The ligated plasmid is isolated using miniprep and the PCR product 
was sequenced using M13 forward (5’-TGACCGGCAGCAAAATG-3’) and M13 reverse 
(5’GGAAACAGCTATGACCATG-3’) primers. The PCR product was isolated by 
digesting the ligated p-Blue script-PCR product with NdeI and XhoI. The PCR fragment 
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was then cloned into pCR2.1 vector containing the 5’UTR.The pCR 2.1 vector containing 
the 5’UTR and the PCR product was digested with Kpn I and Hind III (fragment size 
approx.600bp) and cloned into p-Blue script-pag. Finally the p-Blue script containing the 
5’UTR, Histidine tag and pag was digested with EcoRV and Xba I (fragment size 
approx.2.5kb) and cloned into tobacco universal vector pLD-ctv. 
 
Construction for pLD-5’UTR-HisPA63 vector for transformation tobacco 
Chloroplast 
 
Polymerase chain reaction was performed to introduce His tag and Factor Xa 
protease cleavage site N-terminal to pag using primers forward 5’ –TAACTTACAACA-
TATGCACCATCATCATCATCATTCTTCTGGTATAGATGGAAGAAGTACAAGTG
CTGGA- 3’ and reverse 5’- TTTCATGAATATTCTCGAGCCATGGTGAAAGAAAAG 
- 3’.The PCR amplified product of size approx. 190 bp was obtained with Nde I 
restriction site at the 5’end and Nco I restriction site at the 3’ end as shown in fig 2A. The 
PCR product has the Histag, Factor Xa protease cleavage site, partial pag sequence. The 
PCR product was purified using PCR purification kit (Qiagen). The phosphate groups 
were added to the PCR product to the 5’ ends of both strands and cloned into EcoRV 
digested and dephosphorylated p-Blue script plasmid vector. The p-Blue script containing 
PCR product sequenced. The p-Blue script containing the PCR fragment was digested 
with NdeI and NcoI and cloned into plasmid p-Blue script containing the 5’-UTR-His 
and Pag gene (Full size). The ligated plasmid was digested with EcoRV and Xba I to 
clone into pLD-CtV (fig 2c). 
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Bombardment of the pLD-5’UTR-His-PA83 and pLD-5’UTR-His-PA3 vectors 
Preparation of gold particles 
 
50mg of gold particles (0.6µm in size) and 1ml of 70% EtOH were placed in a 
micro centrifuge tube. The mixture was vortexed for 3-5 minutes and then incubated for 
15 minutes at room temperature. To pellet the gold particles, a quick centrifugation was 
done. The supernatant was discarded and 1ml of dH2O was added to the particles and 
vortexed. The particles were allowed to settle for 1 minute and then a pulse centrifugation 
was performed for 3 seconds, the supernatant was discarded. The previous step was 
repeated three times. The gold particles are stored in 50% glycerol stock at –20°C 
(Kumar and Daniell, 2004). 
Preparation of tobacco tissue culture media  
 
The RMOP media containing MS basal salt mixture (one pack), 30 grams of 
sucrose, 100mg of myo-inositol, 1ml of benzylaminopurine (BAP: 1mg/ml), 100µl of α-
naphtalene acetic acid (NAA: 1mg/ml), 1ml of thiamine hydrochloride (1mg/ml), and 
water 1 liter) was used to regenerate and select the transgenic plants after bombardment. 
The pH was adjusted to 5.8 using 1N KOH. Six grams per liter of phytagar was added to 
the media and autoclaved followed by cooling down and pouring into plates. The MSO 
media containing 30g sucrose, 1 packet of MS basal salt mixture, and water to 1 liter was 
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used to generate roots. The pH was calibrated to 5.8 with 1N KOH and 6g per liter of 
phytagar were added before autoclaving. (Kumar and Daniell, 2004) 
Bombardment protocol for tobacco leaves 
 
The bombardment was performed as described previously (Daniell, 1997).   For 
the bombardment, it is most important to maintain the aspectic conditions. For this all the 
essential equipments were sterilized. The stopping screens, macrocarrier holders, forceps, 
Watman filter paper, kimpwipes were autoclaved prior to bombardment. The 
macrocarriers and the rupture discs were sterilized under hood by immersing them in 
95% ethanol for 15 minutes followed by drying. Fifty µl of gold particles placed in a 
micro centrifuge tube followed by 10µl of DNA (1µg/µl). Fifty µl of 2.5M CaCl2, 20µl of 
0.1M spermidine-free base were added sequentially to the mixture to ensure proper 
binding of DNA to the gold particles. Vortexing was done after addition of each 
component to ensure proper mixing of components and binding of DNA to the gold 
particles. The mixture was then vortexed for 20 minutes at 4°C. Two hundred µl of 
absolute ethanol was added to the vortexed mixture at room temperature and followed by 
a quick spin at 3000 rpm in a microfuge for 30 seconds, supernatant was removed and 
this wash procedure was repeated four times. Finally the gold particles were resuspended 
in thirty ul of 100% ethanol. The gold particles with DNA were placed on ice to be used 
in next two hours. Aseptic tobacco plant Nicotiana tabacum variety Petit havana green 
healthy leaves were cut from a young plant growing in  jars containing MSO media and 
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placed on a Petri dish (100 x 15) containing RMOP media with no selection and a 
Watman filter paper on the top of media. The leaves were placed with the abaxial side 
upwards. The gene gun (Bio-Rad PDS-1000/He) was sterilized in the inside chamber 
with 70% ETOH prior to bombardment. The macro carriers were placed on the 
macrocarriers holders. The gold particles lying on ice were votexed and five µl of gold 
particles containing the DNA were placed on top of the macro carrier. Vortexing is an 
important step while placing the gold particles on the macrocarriers. The rupture disc, 
stopping screens and macrocarrier holders containing the macrocarrier, and the leaf were 
put in place and secured to proceed with the bombardments.  The gene gun and the 
vacuum pump were turned on, and the helium tank was turned to the open positions and 
the valve is turned on till the pressure reaches 1350 psi. The vacuum in the gene gun was 
allowed to build to 28 psi, and was then held briefly and then fired (the fire switch was 
held until the rupture disk broke at ~1100 psi) After the bombardment, the vacuum was 
released, and the Petri dish with the leaf was taken out and covered. After the samples 
were finished they were covered with aluminum foil (to keep them dark) and incubated 
for 48 hours at room temperature. (Kumar and Daniell, 2004) 
 
Tissue regeneration and selection 
 
The leaves, after two days incubation period, were transferred to 100x25 Petri dish with 
RMOP media containing 500µg/ml of spectinomycin final concentration as explained by 
Daniell, 1997. After four to six weeks, the shoots that appeared were cut in 5mm2 pieces 
and transferred to fresh RMOP plus spectinomycin for the second round of selection. 
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Before transferring the shoots to secondary selection, a total DNA extraction and a PCR 
analysis was performed to confirm the integration into the chloroplast on these putative 
transgenic lines. Finally, after 4 weeks on secondary selection, the shoots were 
transferred to a jar that contained MSO media with 500µg/ml spectinomycin (Daniell, 
1997), this step is called the third selection. (Kumar and Daniell, 2004) 
 
Plant genomic DNA extraction procedure 
 
The Qiagen DNeasy Kit was used to isolate plant genomic DNA as described in 
the Qiagen manual. 100mg of tissue sample was taken from the plant using aseptic 
techniques, placed into a micro centrifuge tube, and grinded by using a micro pestle in 
400µl of buffer AP1 and 4µl of RNase A (stock solution 100mg/ml). The mixture was 
incubated for 10 minutes at 65°C and mixed about 2-3 times during incubation by 
inverting the tube. 130µl of buffer AP2 were added to the lysate, vortexed and incubated 
for 5 minutes on ice. Following, a centrifugation was done at maximum speed for 5 
minutes and the supernatant was transferred to a Qiashredder spin column (lilac) sitting 
in a 2ml collection tube. The centrifugation was performed at full speed for 2 minutes. 
The flow through was transferred to a new tube and 1.5 volumes of buffer AP3/E were 
added to the lysate and mixed immediately. 650µl of the mixture was applied to a Dneasy 
mini spin column (clear) and centrifuged for 1 minute at 8000 rpm. The flow through was 
discarded and the collection tube reused to repeat the previous step with the rest of the 
sample. The tube with the flow through was discarded and the column was placed in a 
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supplied 2 ml tube. 500µl of buffer AW were added to the column and centrifuged for 1 
minute at 8,000 rpm. The flow through was discarded, and the tube was reused. The 
Dneasy column was washed once again by using 500µl of AW buffer and by centrifuging 
it for 2 minutes at maximum speed. The Column was transferred to a clean 1.5ml tube 
and 100µl of preheated (65°C) buffer AE were directly delivered into the Dneasy 
membrane. The membrane was incubated for 5 minutes at room temperature and then 
centrifuged at 8,000 rpm for 1 minute to elute the DNA. The DNA was kept at -20°C. 
 
Confirmation of transgene integration into the chloroplast genome 
 
 To confirm the transgene cassette integration into the chloroplast genome, PCR 
was performed using the primer pairs 3P(5’-AAAACCCGTCCTCEGTTCGGATTGC-
3’) -3M (5’-CCGCGTTGTTTCATCAAGCCTTACG-3’) (Daniell et al., 2001a) and to 
confirm the integration of gene of interest PCR was performed using primer pairs 5P(5’-
CTGTAGAAGTCACCATTGTTGTGC-3’ and 2M (5’-TGACTGCCCACCTGAGAGC- 
GGACA-3’) (Daniell et al., 2001a). Positive control (known transgenic plant DNA 
sample) and Negative control (Wild type petit havana DNA sample) were used to 
monitor the PCR reaction. For a 50 ul reaction volume, the PCR was set as follows: 
150ng of plant DNA, 5 µl of 10X buffer, 4µl of 2.5 mM dNTP, 1µl of each primer from 
the stock, 0.5µl Taq DNA polymerase and H2O to make up the total volume. The 
amplification was carried during 25 cycles with a program timed in the following way: 
94°C for 30 sec, 65°C for 30sec, and 72°C for 30sec for the 3P-3M primer pair and 72°C 
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for 1min for the 5P-2M primer pair. Cycles were preceded by denaturation for 5 min at 
94°C and followed by a final extension for 7 min at 72°C. The 5 ul of each PCR products 
including the contorls were loaded into a 0.8% agarose gel to confirm the results. 
 
Southern blot analysis of transgenic plants  
Restriction Digestion of plant genomic DNA 
 
The total plant DNA was extracted from transgenic T0 plants as well as from 
untransformed tobacco plants following the protocol previously explained using Qiagen 
DNeasy Plant Mini Kit. These steps were performed as described in (Daniell et al., 
2004d) The total plant DNA was digested with BglII in a reaction containing: 2ug of 
DNA, 2µl of 10X buffer (New England Biolabs), 2µL of BglII enzyme (New England 
Biolabs) and sterile dH2O to make up the volume upto 20 ul. The reaction was incubated 
overnight at 37°C. All the samples must contain equal quantity of DNA. 
Agarose electrophoresis and DNA transfer 
 
The total 20µl reaction volume was loaded on a 0.7% agarose gel for each of the 
transgenic plant DNA samples. The digested DNA of wild type plant (Nicotiana tabacum 
var Petit Havana) acts as negative control and (unlabeled probe) acts as the positive 
control. The positive control (unlabeled probe) was prepared by digesting the plasmid 
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DNA (pBluescript-gene10-Pag) with NcoI. The 810 bp fragment was diluted 20 times 
and then 1µl of the diluted probe was loaded onto the gel. The gel was run for 2.5 hours 
at 50 volts. After the run was completed, the DNA was transferred by capillary action to a 
nylon membrane. The parts of the gel that were not needed were removed, and the upper 
right corner was cut to help as a guide. The gel was then depurinated by immersing it in 
0.25M HCl (depurinaion solution) for 15 minutes (until the color of the dye became 
yellow). Following, the gel was washed twice in dH2O for 5 minutes, and then 
equilibrated in transfer buffer (0.4N NaOH, 1M NaCl, filled to 1 liter with water) for 20 
minutes. The four pieces of Whatman paper and the membrane were cut to fit the size of 
the gel then the upper right corner of the membrane was removed and washed briefly in 
water. Following, the membrane was equilibrated by immersing it in transfer buffer for 5 
minutes. In a glass tray, a stack of two spongy was placed and enough transfer buffer was 
added to cover the spongy that is in touch with the tray. On top of the spongy two pieces 
of whatman paper were placed and some transfer buffer was poured to soak the paper and 
to remove any air bubbles. The gel was placed facing down on the whatman paper and 
then the nylon membrane was placed with the cut corner touching the cut corner of the 
gel. Some transfer buffer was added to remove any bubbles. Two Whatman papers, and 
then a stack of paper towels were placed on top of the membrane. A 500g weight was 
placed on the paper towels to help the capillary transfer. The set up was left for transfer 
over night and the next day the membrane was washed on 2X SSC (3M NaCl, 0.3M Na 
citrate, H2O, the pH was adjusted with 1N HCl to 7 and water was added to 1L) for 5 
minutes. Following, the membrane was allowed to dry on a whatman paper for 5 minutes 
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and then cross-linked using the Bio-Rad GS Gene Cross Linker at setting C3 (150 m 
joules). The membrane was wrapped in saran wrap and stored in a dry place until use. 
Generation of probes 
 
These steps were performed essentially as previously described (Daniell et al., 
2004d )The flanking sequence probe was obtained from the plasmid pUC-ct vector that 
contains the chloroplast flanking sequences for the trnI and trnA. The digestion reaction 
was setup as follows: 15µl of pUC-ct vector DNA, 2µl of 10X buffer, 1µl of BamHI 
(NEB), 1µl of BglII and 1µl of dH2O. The reaction was performed overnight at 37°C and 
then run in an agarose gel to obtain the desired fragment of 0.8kb. The band was cut out 
and eluted from the gel as explained before. For the final DNA elution, 50µl of H2O was 
used. The gene specific probe was made by cutting out the 0.81kb fragment from pBlue 
script-gene10-PA in a reaction as follows: 2ug of pBlue-gene10-PA, 2µl of 10X buffer, 
1µl of EcoRV (NEB) and 12µl of dH2O. The reaction was incubated overnight at 37°C. 
The fragment of interest (0.81kb) was eluted from the agarose gel and checked for the 




The probes denaturation (45µl of the DNA) was made by incubating the tube at 
94°C for 5 minutes, immediately placing the tube on ice for 2-3 minutes and then pulse 
centrifuging to bring down any droplets. Following, the probe was added to the ready mix 
(Quanttm G-50 Micro columns, Amersham) and mixed by flicking. 5µl of α32P was added 
to the tube and the mixture was incubated for 1 hour at 37°C. Once the incubation period 
was complete, a G50 column was taken and the resin was re-suspended by vortexing, 
then the cap was loosened about ¼ and bottom plug was removed. Then, placed the 
column into a micro centrifuge tube with the top cut off and centrifuged for 1 minute at 
3,000 rpm. The collection tube was discarded and the column was transferred to a new 
1.5ml tube. The DNA probe was added in the center of the resin and spun at 3,000 rpm 
for 2 minutes and the column was discarded. From the labeled probe 1µl was mixed with 
98µl of STE buffer. The mixture was aliquoted into 50µl samples and to each sample 3ml 
of Opti-Fluor was added. The activity of the radioactive probe was measured in a 
Beckman LS 5000TD. The two samples plus a blank containing 3ml of Opti-Fluor were 
placed into the machine holder. The readings were taken by using the auto-read mode of 
the machine. The amount of probe to be used was determined by calculating the amount 
of probe needed to yield 2.5 x 106 cpm/2ml.  The amount of probe was calculated as 
follows: Reading value (502050) was equal to 0.50 x 106 cpm/µl, then multiplied by 50µl 
of total volume of sample for a total of 35 x 106 cpm/µl. Because 5ml of hybridization 
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solution was used, we needed 6.25 x 106 cpm, therefore 6.25 x 106 cpm divided by 0.7 x 
106 cpm is equal to 12.5µl of labeled probe needed. 
Prehybridization, hybridization and washing of membrane  
 
The Quick-Hyb solution from Stratagene was mixed and incubated for 5 to 10 
minutes at 68°C. Following, the blot was placed into the hybridization bottle with the top 
facing in toward the solution and 5ml of the preheated pre-hybridization solution was 
added. The bottle with the membrane was incubated in the Fisher Biotech Hybridization 
Incubator for 1 hour at 68°C. One hundred µl of salmon sperm DNA was added to the 
probe and then heated for 5 minutes at 94°C. Following, 1ml of pre-Hyb solution from 
the bottle containing the membrane was withdrawn and added to the probe solution. 
Immediately, the content was returned to the bottle. The hybridization bottle was 
incubated for 1 hour at 68°C. After the hour of incubation, the quick-Hyb solution was 
discarded into the liquid radioactive waste container.  The membrane was washed twice 
as follows: 50ml of wash solution number 1 (2X SSC and 0.1% SDS) was poured and 
incubated at room temperature for 15 minutes. The liquid was discarded in the liquid 
waste container and the step was repeated. A second round of washes was performed 
twice by pouring 50ml of solution number 2 (0.1X SSC and 0.1% SDS) and incubating it 
for 15 minutes at 60°C to increase the stringency. The liquid of these washes were 
discarded into the radioactive liquid container. The radioactive membrane was wrapped 




The blots were placed into the film cassette and then taken to the dark room. 
Using the safe light (red light), the X-ray film was placed into the cassette on top of the 
blot and the intensifier screen was placed on top of the X-ray film. The cassette with the 
blot and the film was placed into a black bag to protect against light and then incubated 
overnight at –80°C. The next day the cassette was taken out from the –80°C, allowed to 
thaw, and then moved to the dark room where the film was developed. 
 
Characterization of expressed proteins 
Extraction of Protein from Transformed E. coli Cells 
 
  E. coli, XL1-blue cells that have tetracycline resistance gene in their genome, 
were transformed with pLD-His-PA83 and pLD-His-PA63 were grown in 5 ml of 
Terrific broth with ampicillin (100 µg/µl) and tetracycline (50 µg/µl) at 37oC for 14-16 
hrs.  Untransformed E. coli cells were also cultured for use as a negative control. The 
buffers and gels used in this study were made from protocols in SDS-PAGE Buffer 
System below (Laemmli, 1970). After the boiling step (as described below), samples 
were immediately loaded into polyacrylamide gels.  The 800 µl of cultured cells were 
centrifuged for 1 minute at 13,000 rpm.  Supernatant was discarded from pelleted E. coli 
cells then washed with 1ml of 1x Phosphate-Buffered Saline (PBS: 140mM NaCl, 
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2.7Mm KCl, 4mM Na2HPO4, 1.8mM KH2PO4, pH 7.2).   Pellet was resuspended, 
followed by centrifugation for 1 minute at 13,000 rpm.  Supernatant was discarded.  50 µl 
of 1x PBS was added and mixed well to resuspend the pellet.  A mixture containing 425 
µl of 2x loading buffer , also called Sample Buffer or SDS Reducing Buffer (1.25 ml of 
0.5 M Tris-HCl, pH 6.8, 2.0 ml of 10%  (w/v) SDS, 0.2ml of 0.5% (w/v) bromophenol 
blue, 2.5 ml of glycerol, q.s. with dH20 to 9.5 ml, and the 25 µl of β-mercaptoethanol was 
prepared. Equal amounts of sample and the mix of sample loading buffer and β-
mercaptoethanol was taken and Boiled for 5 minutes, then immediately loaded samples 
onto gels. (Sambrook et al., 1989). 
Extraction of Protein from Transformed Tobacco Leaves 
 
 In order to confirm expression of PA83 and PA63 in tobacco plants extracts were 
made from Petit Havana plants. These steps were performed as described in (Daniell et 
al., 2004d). Approx. 100 µg of plant leaf tissue was weighed and ground with a mortar 
and pestle in liquid nitrogen and put into a microcentrifuge tube.  Two hundred µl of 
extraction buffer (100 mM NaCl, 10 mM EDTA, 200 mM Tris-HCl-pH8, 0.05% Tween-
20, 0.1% SDS, 14 mM BME, 400 mM sucrose, 2 mM PMSF) was added and the samples 
were mixed for 3 minutes with a micropestle.  The samples are centrifuged at 13,000 rpm 
for 10min to obtain the supernatant containing the soluble proteins.  20 µl of these 
extracts were mixed with 20 µl of sample loading buffer containing BME was added.  
Samples were then boiled for 5 minutes and loaded into SDS-PAGE gel.  
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SDS-PAGE Buffers and Gels 
 
To detect the PA protein expression in the crude extract obtained from E. coli 
cells or crude extract obtained from the transgenic plant tissue extract transformed with 
pLD-PA83/ pLD-PA63, SDS-PAGE gels were made in duplicate utilizing buffer 
solutions: (1) Bio-Rad (cat#161-0158), 30% Acrylamide/Bis solution according to the 
ratio 37:5:1.  (2) The resolving buffer (5M Tris-HCl, pH 8.8), was used to make the 
resolving portion of the gel. (3) The stacking buffer (0.5M Tris-HCl, pH 6.8), was used to 
make the stacking gel layer, concentrated the samples at top of the resolving gel to 
improve resolution. (4) 10x Electrode buffer: 30.3g Tris base, 144.0g glycine and 10.0g 
SDS q.s. to 1000 ml dH20. and stored at 4°C, (5) 2x loading buffer, also called the 
Sample buffer and the SDS Reducing Buffer: see previous section. (6) 10% (w/v) Sodium 
Dodecyl Sulfate (SDS). (7) N,N,N,N’-Tetra-methyl-ethylene diamine (TEMED) from 
BIO-RAD (cat# 161-0800). (8) 20% Ammonium Persulfate (APS): Dissolved 20 mg of 
APS into 1ml dH20 in an micro centrifuge tube and stored at 4ºC for about a month. The 
8% resolving gel was made by the following method: Added 4.0 ml of 30% 
Acrylamide/Bis, 2.5ml of resolving buffer, 3.4 ml dH20 and 100 µl of 10% SDS to a 50 
ml flask.  Added 40 µl of 20% APS (#8 above) and then 10 µl of TEMED and used to 
cast the gel mixture between the two, vertical, glass plates (Mini-Protean 3 Cell gel 
system, Bio-Rad) leaving about 1.5 cm at the top of glass plates for the stacking gel. The 
gel is allowed to polymerize for 20 minutes. To make the 4% stacking gel, 1.3 ml of 30% 
Acrylamide/Bis, 2.5 ml of the stacking buffer, 6.1 ml dH20 and 100 µl of 10% SDS are 
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taken together into a flask followed by 40 µl of 20% APS and 10 µl of TEMED. The 4% 
gel mixture is layered on top of resolving gel, and then the comb is inserted for the 
formation of wells. After polymerization for about 20 minutes, the comb is removed and 
the gel was put vertically into PAGE apparatus containing 1x Electrode (running) buffer. 
20 µl of protein extract along with the sample loading buffer was loaded along with PA 
protein standard, and 10 ul protein marker. Gel was ran at 50V until samples stacked onto 
the top of the resolving gel, then ran gel at 80V for 2-3 hours so that protein marker 
bands could spread out sufficiently. 
Transfer of protein and analysis of Western Blot 
 
The separated proteins were transferred onto a 0.2 µm Trans-Blot nitrocellulose 
membrane (Bio-Rad) by electroblotting in Mini-Transfer Blot Module at 80V for 
45minutes in Transfer buffer (360 ml of 10x Electrode buffer, 360 ml of methanol, 0.18 
grams of SDS, 1080 ml distilled H20). For Western blotting, the proteins were transferred 
to nitrocellulose membranes and then blocked for one hour in P-T-M (PBS [12 mM 
Na2HPO4, 3.0 mM NaH2PO4-H2O, 145 mM NaCl, pH 7.2], 0.5% Tween 20, and 3% Dry 
Milk) followed by transfer to P-T-M containing anti-PA monoclonal antibody. 
Membranes were then washed with distilled water and transferred to P-T-M containing 
goat derived anti-mouse IgG antibody conjugated with Horseradish peroxidase (Sigma, 
St. Louis, MO).  Blots were washed three times with PBST for 15 minutes each time.  
Then washed with PBS for 10 minutes, followed by addition of Lumiphos WB (Pierce, 
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Rockford, IL) as a substrate for HRP and incubating at room temp for 5 min for the 
chemiluminescence. Later the X-ray films were exposed to chemiluminescence and the 
films were developed in the film processor to visualize the bands.  
Comassie Staining of the protein gel 
 
The Comassie staining was performed using the Comassie dye-250 Brilliant blue 
(Bio-Rad). The concentrated dye was diluted 5 times with distilled water. The protein gel 
was SDS-PAGE was incubated in the stain for 30 minutes at room temperature followed 
by destaining over night with destain solution at room temperature. The gel was allowed 
to dry in Vacuum dryer. 
Enzyme Linked Immuno Sorbant assay (ELISA) 
 
The quantification of PA in the plant crude extract was done using the enzyme 
linked immunosorbent assay (ELISA). 100mg of transgenic leaf samples (young, mature, 
old) and the wild type leaf samples (young, mature, old) were collected. The leaf samples 
were collected from plants exposed to regular lighting pattern (16 h light and 8 h dark), 3 
day continuous light, and 5 day continuous light.  The leaf samples were finely ground in 
liquid nitrogen, followed by collection of leaf powder into the eppendorf tube. To extract 
the protein from the plant leaf powder, plant protein extraction buffer (15mM Na2CO3, 
35mM NaHCO3, 3mM NaN3, pH: 9.6, 0.1% Tween, 5mM PMSF) was used to resuspend 
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the ground mixture. The Mechanical pestle was used to agitate the leaf tissue so that the 
all the soluble protein comes out of the chloroplast and cytosol into the buffer. In order to 
check the protein concentration, the standards, test samples and antibody were diluted in 
coating buffer (15mM Na2CO3, 35mM NaHCO3, 3mM NaN3, pH: 9.6)The standards 
ranging from 50 to 500 ng/ml were made by diluting purified PA in coating buffer. The 
standards and protein samples (100 µl) were coated to 96-well polyvinyl chloride 
microtiter plate (Cellstar) for 1 h at 37 ◦C followed by 3 washes with PBST and 2 washes 
with water. Blocking was done with 3% fat-free milk in PBS and 0.1% Tween and 
incubated for 1h followed by washing. The primary anti-PA antibody (Immuno 
Chemicals) diluted (1:1000) in PBST containing milk powder was loaded into wells and 
incubated for 1h followed by washing steps and then again incubated with 100 µl of anti-
mouse IgG-HRP conjugated antibody made in goat (American Qualex) (1: 5000) diluted 
in PBST containing milk powder. The plate was then incubated for 1h at 37 °C. After the 
incubation the plate was washed thrice with PBST and twice with water. The wells were 
then loaded with 100 µl of 3,3,5,5-tetramethyl benzidine (TMB from American Qualex) 
substrate and incubated for 10–15 min at room temperature. The reaction was terminated 
by additing 50 µl of 2N sulfuric acid per well and the plate was read on a plate reader 
(Dynex Technologies) at 450 nm. (Modified form of protocol from Ausubel et al., 4th 
edition). 
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Bradford assay for protein quantification   (Bio-rad manual). 
The Bradford assay was used to determine the total protein from the plant extracts 
prepared as described above.  This was used to determine the percent of PA antigen in the 
total soluble protein extract (or %TSP). An aliquot of plant extract as prepared above was 
thawed on ice.  Extraction buffer (15 mM Na2CO3, 35 mM NaHCO3, 0.2 g NaN3, 0.1% 
Tween 20, and 5mM PMSF adjusted to pH 9.6) was used to make Bovine Serum 
Albumin (BSA) standards ranging from 0.05 to 0.5 µg/µl.  Plant extracts were diluted 
1:5, 1:10 and 1:20 with extraction buffer.  10 µl of each standard and 10 µl of each plant 
dilution was added to the wells of a 96 well microtiter plate (Costar) in duplicates.  
Bradford reagent (Biorad protein assay) was diluted 1:4 with distilled water as specified 
and 200 µl was added to each well. Absorbance was read.  Comparison of the absorbance 
to known amounts of BSA to that of the samples was used to estimate the amount of total 
protein.  
 
Macrophage lysis assays  
 
 
Macrophage lysis assay was performed on the crude leaf extracts.  For this 
approximately 100 mg of leaf tissue was ground finely in liquid nitrogen. Plant proteins 
were extracted with 200 µl of plant protein extraction buffer (15 mM Na2CO3, 35 mM 
NaHCO3, 0.2 g NaN3, 0.1% Tween 20, and 5mM PMSF. The plant tissue along with the 
buffer were centrifuged for 5 min at 10,000 g and the supernatant containing the soluble 
proteins was placed in a new tube. RAW264.7 macrophage cells were plated in 96-well 
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plates in 120 µl DMEM medium and grown to 50% confluence. The medium was 
aspirated and replaced with 100 µl medium containing 250 ng/ml LF. The control plate 
received medium with no LF to test toxicity of plant material and buffers. In separate 96-
well plates, the plant samples were diluted serially two-fold and 40 µl of the dilutions 
were transferred onto the RAW264.7 cells. so the top row had plant extract at 1:14 
dilution. MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) was added 




The purification steps were performed as described in Amersham biosciences 
chromatography manual. The PA protein expressed in the transgenic plant has the His-
tag. The HIS affinity chromatography with nickel column 1ml size (Amersham 
biosciences) was used to purify the protein. The following buffers were prepared to 
purify the PA protein from the crude extract. To obtain the crude extract, the plant leaves 
(6grams) were finely ground in liquid nitrogen. The protein was extracted using 15 ml of 
plant protein extraction buffer (15 mM Na2CO3, 35 mM NaHCO3, 0.2 g NaN3, 0.1% 
Tween 20, and 5mM PMSF adjusted to pH 9.6). The mechanical pestle was used to churn 
the leaf tissue for 15 minutes in order to extract protein from the plant tissue. The extract 
was transferred to sorvall tube and centrifuged at 10,000 rpm for 10 minutes. The 
supernatant was transferred into a new falcon tube. The supernatant was stored at –80°C 
before use. The buffer used for purification are as follows: Binding Buffer: 20mM 
Sodium Phosphate, 0.5M Sodium Chloride, 10 mM Imidazole, pH 7.4., Elution Buffer: 
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20 mM Sodium Phosphate, 0.5M Sodium Chloride, pH 7.4., Ni-Loading Eluent:100mM 
Nickel Sulfate solution (Sigma). Purification operations were performed on the Akta 
prime machine (Amersham biosciences). The Binding buffer is passed into the 
purification set up through A1 port, Elution buffer through Port B, Nickel sulphate 
solution through A2 port and water through A3 port.  The purification steps are carried 
out in as following. Washing the column with elution buffer and water, followed by the 
loading the column with nickel sulfate solution, equilibrating the column with binding 
buffer, application of sample, followed by washing and gradient elution. The samples 
were collected in 1000ul volume .The samples corresponding to the peak were aliquoted 
for further analysis. The flow through was collected to analyze the loss of PA through 
flow through. The protein aliquots, flow through samples were analyzed for presence / 
absence of PA using ELISA. The binding buffer, elution buffer were used as negative 
controls. The fractions containing the purified PA83 were pooled together and dialyzed 
against phosphate buffer saline (PBS), pH 7.4 using the dialysis cassette 10K MW 
(Pierce) to replace the Imidazole buffer. The purified PA in PBS was loaded onto the 
protein concentrator columns (Millipore) and centrifuged at 3000 rpm until to concentrate 
the protein. 
 
Immunization studies in mice 
 
7 groups of Balb/c mice, 6-7 weeks old (Charles river laboratories) were 
immunized subcutaneously at 2 sites 100µl per site on day 0. The injection doses were 
prepared using 5µg of chloroplast derived PA/PA derived from Bacillus anthracis and 
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50µl of alhydrogel adjuvant in phosphate buffer saline so that the final volume is 200ul 
per dose. This suspension was allowed to mix thoroughly in a shaker at 225rpm at 4°C 
for 2-3 hrs to allow the PA bind to alhydrogel. The measurement of PA adsorbed to 
alhydrogel was done according to (McBride et al., 1998). Two of the groups were 
immunized without the adjuvant. The plant protein crude extract has been dialyzed 
against the PBS to eliminate the protein extraction buffer and replaced it with PBS.  The 
doses were given on day 0 followed by booster doses at the end of 2nd and 4th week. On 
the 14th day after the last booster blood was drawn from the retro orbital plexus and 
collected in the microtainer tubes (Fisher Scientific). The blood samples were allowed to 
stay undisturbed for 2 hours at room temperature and stored at 4°C over night. (Miller et 
al., 1998,  Reuveny et al., 2001, Gaur et al., 2002). The experimental parameters are 
summarized in the table below. 
 
Table 1: Immunization studies of plant derived PA in mice 
Group 
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ELISA to detect the anti-PA IgG antibodies in the serum samples 
 
96 well microtiter ELISA plates were coated with 100ul/well of PA standard at a 
concentration of 2.0µg/ml in Phosphate buffer saline solution, pH 7.4. The plates were 
stored overnight 4°C. The plates were washed and blocked with PBS containing 0.1% 
Tween 20 and 3% skim milk powder.    The serum samples from the mouse were serially 
diluted ranging from 1:100 to 1: 640,000. Plates were incubated with 100ul of diluted 
serum samples for an hour at 37°C followed by washing with PBS-Tween and Water.   
The plates were then incubated for one hour at 37°C with 100µl of Goat anti-mouse IgG 
conjugated with Horseradish peroxidase enzyme (1:5000 dilution). This is followed by 
washing and addition of 100µl of TMB substrate and incubating the plate for 10min at 
room temperature. The reaction is finally stopped by adding 50µl of 2M sulphuric acid. 
The plates are read on the plate reader (Dynex technologies) at 450 nm.    Titer values are 
calculated using a cut off value equal to an absorbance difference of 0.5 between 
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immunized and unimmunized mice. (Quinn et al., 2002, Schneerson et al., 2003, Pezard 
et al., 1995, Gaur et al., 2002). 
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RESULTS 
Construction of pLD-5’UTR-HisPA83 vector for tobacco chloroplast 
transformation 
  
The 6Xhistidine tag and the factor Xa site with Nde I and Xho I restriction sites 
were introduced N-terminal to pag using polymerase chain reaction. PCR amplified 
product of size app. 370 bp with Nde I restriction site at the 5’end and Xho I restriction 
site at the 3’ end was obtained by performing site directed mutagenesis. The PCR product 
has the Histag, Factor Xa protease cleavage site, partial pag sequence as shown in fig 1a. 
The PCR product was purified using PCR purification kit (Qiagen). Phosphate groups 
were added to the PCR fragments to the 5’ ends of both strands and cloned into EcoRV 
digested and dephosphorylated p-Bluescript plasmid vector.   The transformed colonies 
were selected based on blue-white selection. Among the white colonies picked, 90% 
contained the plasmid with the ligated PCR product. The ligated plasmid designated as 
pBsk-pag1 was isolated using miniprep and the PCR product was then sequenced. The 
sequence was compared with sequence sent by Dr. Bhatnagar which is currently available 
in NCBI data base with accession number AY700758. The PCR product was isolated 
digesting the ligated pBsk-pag1 with NdeI and XhoI. The PCR product was then cloned 
into pCR2.1 vector containing the 5’UTR as shown in fig1B and is designated as 
pCR2.1-pag1. (5”UTR is a regulatory sequence derived from the plant psbA gene that 
helps in transcription enhancement due to the presence of promoter in the sequence and it 
is a  light and developmentally regulated translation enhancer). The pCR 2.1 vector 
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containing the 5’UTR and the PCR product was digested with Kpn I and Hind III 
(fragment size app.600bp) and cloned into p-Bluescript-pag, designated as pBsk-pag2 as 
shown in Fig1C. Finally the p-Blue script containing the 5’UTR, His tag and pag was 
digested with EcoRV and Xba I (fragment size app.2.5kb) and cloned into tobacco 
universal vector pLD-ctv, designated as pLD-VK1 as shown in fig1D.  The pLD vector 
contains the homologous recombination sequences (flanking sequences) that allowed the 
homologous recombination of the gene cassette (aadA, 5’UTR,His PA) in between the 
trnI and trnA of the chloroplast genome (Daniell et al., 2001a). Downstream to the trnI, 
the vector provided the constitutive 16S rRNA promoter, which regulates the expression 
of aadA gene (aminoglycoside 3’ adenyltransferase) that confers resistance to 
spectinomycin-streptomycin and the His PA gene encoding the protective antigen 
(Goldschmidt-Clermont, 1991). Downstream to the trnA, the vector contains the 3’UTR 
which is a terminator and transcript stabilizer derived from psbA gene. 
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Figure 1: Schematic steps to clone pLD-5’UTR-HIS-PA83 
1A: PCR product showing 6X Histidine tag, factor Xa protease site, pag (partial) with Nde I and 
XhoI restriction sites. 
1B: Cloning of PCR product into pCR2.1 using NdeI and XhoI (pCR2.1-pag1). 
1C: Cloning of pCR2.1 5’UTR into p-Blue script containing pag using kpn I and Hind III 
restriction  sites (pBsk-pag2). 
1D: Cloning of pag with 5’UTR into pLD-Ctv using EcoRV and XbaI restriction sites (pLD-
VK1). 
 
Construction of pLD-5’UTR-HisPA63 vector for tobacco chloroplast 
transformation 
 
This vector was designed to knock out the sequence encoding the N-terminal 
20kDa portion of PA83 protein. This PCR amplified product of size app. 190 bp has been 
obtained with Nde I restriction site at the 5’end and Nco I restriction site at the 3’ end as 
shown in fig 2A. The PCR product has the Histag, Factor Xa protease cleavage site and 
the partial pag sequence. The PCR fragment was purified using PCR purification kit 
(Qiagen). Phosphate groups were added to the PCR fragment, to the 5’ ends of both 
strands and cloned into EcoRV digested and dephosphorylated p-Blue script plasmid 
vector and is designated as pBsk-pag63-1. The transformed colonies were selected based 
on blue-white selection. Among the white colonies picked, 90% contained the plasmid 
with the ligated PCR product. The p-Bluescript containing PCR fragment was sequenced. 
The p-Blue script containing the PCR product was digested with NdeI and NcoI and 
cloned into plasmid p-Blue script containing the 5’-UTR-His and Pag (full size), 
designated as pBsk-pag63-2 fig 2b.The ligated plasmid was digested with EcoRV and 
Xba I to clone into pLD-CtV, designated as pLD-VK2 as shown in fig 2c.All the 
plasmids are stored at –20ºC. 
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Figure 2: Schematic steps to clone pLD-5’UTR-HIS-PA63 
2A: PCR product showing 6X histidine tag, Factor Xa site, NdeI and Nco I restriction 
sites. 
2B: Cloning of PCR product into p-Blue script containing pag using NdeI and NcoI  
restriction sites (pBSk-pag63-2). 




PCR Analysis of Confirmation of Chloroplast Integration of transgenes 
 
After bombardment of tobacco leaves with gold particles coated with plasmid 
DNA (pLD-5’UTR-HisPA83/ pLD-5’UTR-HisPA63), about 5 shoots appeared after a 
period of 5-6 weeks. There were 3 possibilities for obtaining shoots on the selection 
media: chloroplast transgenic, nuclear transgenic, or mutant shoots.  Spontaneous 
mutation of the 16S rRNA gene, which confers resistance to spectinomycin in the 
ribosome, could allow plants to grow on spectinomycin without integration of the gene 
cassette.   The aadA gene in the gene cassette confers resistance to spectinomycin.  True 
chloroplast transformants were distinguished from nuclear transformants and mutants by 
PCR.  Two primers, 3P and 3M, were used to test for chloroplast integration of transgenes 
(Daniell et al., 2001a).  3P primer landed on the native chloroplast DNA in the 16S rRNA 
gene. 3M landed on the aadA gene as shown in fig 3a.  Nuclear transformants were 
eliminated because 3P will not anneal and mutants were eliminated because 3M will not 
anneal. The 3P and 3M primers upon chloroplast integration of transgene will yield a 
product of 1.65kb size fragment as shown in figure 3b, 3c. 
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The Integration of the aadA, His+PA83gene and aadA, His+PA63gene, were 
additionally tested by using the 5P and 2M  primer pair for the PCR analysis . The 5P and 
2M primers annealed to the internal region of the aadA gene and the internal region of the 
trnA gene respectively as shown in fig 3A (Daniell et al., 2001a). The product size of a 
positive clone is of 3.9 kb for PA83 and 3.4 kb for PA63, while the mutants and the 
control do not show any product. Figure 3D shows the result of the 5P/2M PCR analysis 
After PCR analysis using both primer pairs, the plants were subsequently transferred 





                                                                       










   3A 
 5P 
 3P 
16s      trnA3’psbA5’psbA/PAaadAPrrntrnIrRNA
3M















    
                                                                                                                  
 
Figure 3: PCR analysis of Wild type and putative transformants of pLD-5’UTR-
HisPA83/PA63 
3A) PCR using specific primers land within the native chloroplast genome (3P/3M) to 
yield a 1.65 kb product. 3B: Lane1: 1 kb DNA Ladder, Lane2: Wild type, Lane 3-6:  
Transgenic lines pLD-5’UTR-HisPA83, Lane 7: Positive control (Interferon clone).  3C: 
Lane1: 1 kb DNA Ladder, Lane2: Positive control (Interferon clone), Lane 3: Wildtype, 
Lane 4-8:  Transgenic lines pLD-5’UTR-HisPA63. 3D. Lane1: 1Kb plus DNA ladder, 
Lane 2: Wild type, Lane 3,4: Transgenic lines pLD-5’UTR-HisPA83, Lane 5,6: 
Transgenic lines pLD-5’UTR-HisPA63. 
 
Southern Analysis of transgenic plants 
 
The plants that tested positive for the PCR analysis were moved through three 
rounds of selection and were then tested by Southern analysis. The DNA of the full 
regenerated clones growing in jars (third selection) was extracted and used for the 
Southern analysis.  The flanking sequence probe of 0.81kb in size allowed detection of 
the site-specific integration of the gene cassette into the chloroplast genome; this was 
obtained by double digesting the pUC-ct vector that contained the trnI and trnA flanking 
sequences (fig.4A) with BamHI and Bgl II (Daniell et al., 2001a). Figures 4b and 4c 
show the BglII sites used for the restriction digestion of the plant DNA for pLD-His-
Fig: 3D 




PA83 and pLD-His-PA63 constructs respectively. The transformed chloroplast genome 
digested with BglII produced fragments of 5.2 kb and 3.0 kb for pLD-PA83 and 5.2 kb 
and 2.5 kb for pLD-PA63 constructs (Fig 4D), while the untransformed chloroplast 
genome that had been digested with BglII formed a 4.47kb fragment.  The flanking 
sequence probe can also show if homoplasmy of the chloroplast genome has been 
achieved through the three rounds of selection. The plant expressing PA83 showed slight 
degree of heteroplasmy as few of the wild type genomes were not transformed. Whereas 
the plant expressing PA63 showed homoplasmy. The gene specific probe of size 
approx.0.52 kb was used to show the specific gene integration producing a fragment of 
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Figure 4: Southern blot analysis of pLD-5’UTR-His-PA83 and pLD-5’UTR-His-
PA63 
Schematic diagram of expected products from digestion of (A) wild type untransformed 
plant (B) Plants transformed with pLD-5’UTR-His-PA83 (C) pLD-5’UTR-HisPA63 
showing homoplasmy. D) Southerns with flanking sequence probe in pLD-5’UTR-His-
PA83 transgenic lines showing slight heteroplasmy: Lane1: Wild type, Lane 2: 
Transgenic line 1, Lane 3: Transgenic line 2, Lane 3: Transgenic line 3.E) Southerns with 
flanking sequence probe showing homoplasmy in pLD-5’UTR-His-PA63 transgenic 
lines: Lane1: Wild type, Lane 2: Transgenic line # 1, Lane 3: Transgenic line # 2, Lane 3: 
Transgenic line # 3. F) PA gene specific probe showing the presence of pag in the 
transgenic plants: Lane 1: Wild type, Lane 2,3,4: pLD-5’UTR-His-PA83 transgenic lines, 
Lanes 5,6,7: pLD-5’UTR-His-PA63 transgenic lines 
 
                                  
Immunoblot analysis  
 
Crude protein extract of 2ug, was loaded in each well of the SDS-PAGE. The 
western blot analysis with anti-PA monoclonal antibody revealed the full-length 83 kDa 
protein. The 83 kDa PA has several protease cleavage sequences like furin cleavage sites 
trypsin and chymotrypsin cleavage site within the amino acid sequences. The cleavage of 
these protease sites would result in a 63 kDa, a 47 kDa, and a 37kDa band for furin, 
trypsin and chymotrypsin site respectively. The absence of these bands reveals that the 
full-length protein is intact within the chloroplast (See Fig 5A).   Occasionally, break 
down of protein was observed due to repeated freezing and thawing. The supernatant 
samples from wild type plants did not show any band indicating that anti-PA antibodies 
did not cross-react with any plant protein in the crude extract. Immunoblot analysis of 
crude extracts of plants expressing PA63 revealed lower levels of expression of PA63. 
Each lane was with loaded with 30ug of protein crude extract .The blot shows the relative 
expression levels of PA83 and PA 63 (Fig5B). 
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Figure 5: Immunoblotting analysis of  crude extracts of plants expressing 
PA83/Pa63  5A: Western blotting demonstrating the expression of PA in transgenic 
plant crude extracts:  Lane1: Wildtype, Lane 2: 100ng Standard, Lane 4: Transgenic 
line5, Lane 6: Transgenic line 7, Lane 8: Transgenic line 8, Lane 3,5,7: Empty.5B: 
Western  blotting demonstrating the expression of PA63 in transgenic plant crude 
extracts in comparision with expression of PA83:  Lane1:  Crude extract of transgenic 
line expressing PA83, Lane 2: Transgenic line #1expressing PA63+His, Lane3: 
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Protein quantification using ELISA 
 
The standard curve has been obtained using different dilutions of purified PA83 
produced in Bacillus anthracis. The dilutions were made in coating buffer. To estimate 
the expression levels of recombinant PA83 protein, the known concentrations of 
transgenic plant’s total soluble protein was compared with that of the known 
concentrations of purified PA antibody complex (standard curve). The PA83 protein 
expression levels of pLD-5’UTR-PA83 plant of T0 generation reached up to 4.48% of 
total soluble protein (TSP) in mature leaves under the regular illumination conditions 
(16hrs light and 8hrs dark)(Fig 6A) while the pLD-5’UTR-PA63 plant of T0 generation 
reached up to 0.8% TSP (Fig.6B). The psbA regulatory sequences, including the 
promoters and UTRs, have been shown to enhance translation and accumulation of 
foreign proteins under continuous light (Fernandez et al., 2003). Therefore, the pLD-
5’UTR-PA83 transgenic lines were exposed to continuous light (24hrs) and expression 
patterns were observed on day1, 3,5 and 7(Fig 6A). The PA83 expression levels reached 
up to maximum of 14.17 % of total soluble protein (TSP) in mature leaves at the end of 
day 5 and the expression levels declined to 11.73 % TSP on day 7 (Fig 6A). The 
maximum expression levels in mature leaves upon 5 day continuous illumination reached 
up to 1.84 mg per gram of fresh leaf weight. The maximum PA83 expression was 
observed in mature leaves compared to young and old leaves (Fig 6A). The large 
contribution of PA from the mature leaves was due to the high number of chloroplasts in 
mature leaves and the high copy number of chloroplast genomes (up to 10,000 copies per 
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cell) resulting in very high levels of PA expression in mature leaves. The decrease in PA 


















Figure 6: Quantification of expression of levels of PA83 and PA63 in T0 generation 
A) Expression levels in %TSP of PA83 expressing leaves (Young, Mature and Old) 
under normal and continuous illumination observed for 0-7 days. B) Expression levels in 













































Purification of chloroplast derived PA 
 
 The leaves were collected from the transgenic plant expressing PA83.The leaf 
material (6grams) was ground into fine powder in motor pestle using liquid nitrogen. The 
ground material was taken into falcon tube and the material was churned in plant 
extraction buffer (15 mM Na2CO3, 35 mM NaHCO3, 0.2 g NaN3, 0.1% Tween 20, and 
5mM PMSF adjusted to pH 9.6). The supernatant was collected after centrifugation at 
10,000 rpm for 15min.  The supernatant was loaded onto the sample loop of Akta prime 
machine. The sample (supernatant of leaf extract) volume was made sure not to exceed 
more than sample loop volume. First the column was primed with Elution buffer to get 
rid of salts or any proteins in the resin followed by washing with water. Then the column 
was applied with 100mM Nickel Sulfate solution followed by washing with water to get 
rid of the excess of Nickel Sulfate. After Nickel application, binding buffer was passed 
through the column to aid in binding of proteins. This was immediately followed by 
sample application. The excess non-specific proteins that are binding to the column was 
washed with water. During this wash, the flow through was collected to check if the 
protein if interest was being washed away. Finally the PA83 protein with Histag was 
eluted using elution buffer containing 0.5M Imidazole in a gradient manner (Fig 7A). The 
protein eluted at 30% Imidazole gradient. The pooled fractions containing purified plant 
derived PA83 was dialyzed against ice-cold Phosphate buffer saline (PBS) (200 volumes) 
over night to displace the imidazole in the elution fractions with the PBS. Finally the 
protein was loaded onto the 50K MW protein concentrator column to obtain concentrated 
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protein. The concentrators were centrifuged at 3000 rpm until the volume reached 
1000ul.The Column flow through was saved to check for presence of proteins. To 
visualize the purified protein, SDS-PAGE was run with purified fractions. Fig 7Bshows 
the comassie staining of the purified protein, flow through and with the crude leaf 
extracts of PA83 expressing and wild type plant. Upon staining with comassie, the gel 
shows the purified PA83 protein and also shows that absence of PA83 protein being 










































Figure 7: Protein purification 
7A: 1.Points to the wash Peak, 2. Points to the Elution Peak, Elution peak obtained using 
gradient of 0.5M Imidazole. Fig7B: Comassie staining of the proteins in crude extract 
and purified protein: Lane1: Protein plus precision Ladder, Lane2: Wild type leaf 
crude extract, Lane3: Crude extract of transgenic plant expressing PA83, Lane 4,5: 
Purified chloroplast derived PA, Lane6: Flow through collected during purification. 
7C: Lane1: Ladder, Lane3: Concentrated protein, Lane5: Purified protein (before con-
centrating), Lane2 &4: Over flow from lane3. 
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Macrophage lysis assay 
 
Supernatant samples from crude extracts of plant leaves expressing PA83 with 
Histag and PA63 with His Tag, purified chloroplast derived PA83 with His tag were 
tested for functionality in vitro. The functionality of the chloroplast-derived PA83 was 
determined by its ability when PA83 gets cleaved by furin protease into PA63 followed 
by internalization of the lethal factor and cause lysis of cultured mouse macrophages. The 
percentage macrophage viability was determined using the ability of live but not dead 
cells to reduce a water-soluble yellow dye, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide) to an insoluble purple formazan product. The transgenic 
plants were shown to produce fully functional PA83 (Fig.8). A comparative assay was 
done on the supernatant samples of crude extract of PA83 with his tag, crude extract of 
PA63 with his tag, purified chloroplast derived PA with his tag (20ug/ml) and the PA 
purified from Bacillus anthracis of known concentration (20ug/ml) as positive control. 
Crude extract of wild type tobacco plant and plant extraction buffer were used as negative 
controls. The PA83 binds to the anthrax toxin receptor on the macrophages and gets 
cleaved to PA63 with the furin like proteases and allows the lethal factor to bind to the N-
terminal of PA63 followed by internalization. The functional assays revealed that the 
crude extract of PA83 with his tag and the purified chloroplast derived PA83 with His tag 
were able to lyse the mouse macrophages on combining with lethal factor. It was also 
determined that the crude extract of plant leaves expression PA83 and purified 
chloroplast derived PA83 contained about 20ug/ml of functional PA. The PA 63 with his 
tag acted as a negative control because of the absence of furin protease cleavage site that 
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was necessary for the lethal factor to bind to PA63 upon cleavage. The plant protein 
extraction buffer and the crude extract of wild type leaf did not showed no activity 
proving the absence of toxicity due to the buffer and plant extract components. 
 
Figure 8: Macrophage lysis assay 
The cytotoxicity of PA-LF on macrophage cell lines was analyzed on various sources of 
PA. Supernatant samples of plant leaves extracts expressing PA83 with Histag (PA T 
ext), and PA63 with Histag (PA63 Text), Wild type plant crude extract (T ext), Purified 
chloroplast derived PA (PA T pur), Purified PA derived from Bacillus anthracis (PA BA 
pur) and plant protein extraction Buffer. 
 
 
Immunization in mice 
 
7 groups of mice each containing 5 mice were injected subcutaneously with 
antigen doses as per the table given in materials and methods section. The doses were 
given on day 0,14,28. Blood was collected from retro orbital plexus on 14th day after the 
Fig 8 
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final dose. Serum was extracted and performed ELISA for the antibody titers.  The results 
of the immunological studies are summarized in the Fig 9. All the groups injected with 
either purified PA83 or crude extract of plant expressing PA83 responded with significant 
IgG anti-PA levels. The Group of mice that received purified chloroplast derived PA83 
with adjuvant showed a maximum IgG titers of 1:320,000 and the group that received 
PA83 from Bacillus antharcis with adjuvant also reached maximum IgG titers of 
1:320,000. This observation that chloroplast derived PA83 and PA derived from Bacillus 
anthracis elicit comparable immune responses shows that the plant derived PA83 has 
been properly folded and functionally similar to that of PA derived from Bacillus 
antharcis. The group that received purified plant derived PA without adjuvant showed 
titers ranging from 1:40,000 to 1:80,000. The group that received PA derived from 
Bacillus anthracis without adjuvant showed titers 1:80,000 to 1:160,000. Difference in 
the titer values of the groups that received PA83 with adjuvant and the group without 
adjuvant was due to the slow release of PA83 bound to the adjuvant so that the effect of 
PA on the immune system lasts for longer time. The group that received transgenic plant 
crude extracts expressing PA83 with adjuvant showed IgG titers ranging from 1:40,000 
to 1:80,000. The group that received wild type plant leaf crude extract showed no anti PA 
IgG titer value, indicates the specificity of the immune response.  
                                                   
 
















Figure 9: ELISA for detection of IgG Antibody Titers in Serum samples collected 
from mice on Day 14 after final booster 
Comparison of immune responses in mice injected with Chloroplast derived PA (CpPA), 
Std.PA derived from Bacillus anthracis with and without adjuvant, Subcutaneous/Oral. 
 
 
Immunoblotting with serum of mice immunized with purified chloroplast derived 
PA  
 
The crude extracts of plants expressing PA83 and the Bacillus anthracis 
protective antigen (PA83) were run on SDS –PAGE, transferred onto nitrocellulose 
membrane. The membrane was incubated with serum at 1:10000 dilution obatined from 
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able to recognize the chloroplast derived PA as well as PA derived from Bacillus 
anthracis. The serum antibodies did not cross react with any other plant proteins proving 
the specificity of the antibodies. 
 
 






Figure 10: Immunoblotting with serum of mice immunized with purified chloroplast 
derived PA83 
Lane1: Ladder, Lane 2,4,6: Crude extracts of plants expressing PA83, Lane7: PA derived 
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The pLD-5’UTR-His-PA83/63 vector was derived from the universal 
transformation vector, pLD-CtV (Daniell H., 2001a).  The pLD-5’UTR-His-PA83/63 




Figure 11: The Chloroplast Genome 
Arrows point to trnI and trnA where homologous recombination occurs between the 
chloroplast and the pLD-5’UTR-His-PA83/63 vector. 
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region, integrates the transgene cassette into the trnI – trnA region of the chloroplast 
genome via homologous recombination (Fig: 11).  Integration takes place in one of the 
inverted repeats and is copied into the other inverted repeat via the mechanism of copy 
correction (Devine and Daniell, 2004). Expression of the PA83/63 recombinant protein in 
the chloroplast depends on several factors.  First, the pLD-5’UTR-His-PA83/PA63 vector 
is designed to integrate into the inverted repeat region of the chloroplast genome via 
homologous recombination.  The copy number of the transgene is thus doubled when 
integrated at this site.  Increased copy number results in increased transcript levels 
resulting in higher protein accumulation (Daniell et al., 2001a). Second, the 5’ and 3’ 
untranslated regions (UTRs) used for the regulation of transgene expression help in 
enhancing translation of the foreign protein (Eibl et al., 1999).  Third, homoplasmy of the 
transgene is a condition where all of the chloroplast genomes contain the transgene 
cassette.  There are 100 to 1000 chloroplasts per cell and 100 to 1000 chloroplast 
genomes per chloroplast (Daniell et al., 2002, Decosa et al., 2001, Devine and Daniell, 
2004); for optimal production of the recombinant protein and transgene stability, it is 
essential that homoplasmy be achieved through several rounds of selection on media 
containing spectinomycin. If homoplasmy is not achieved, heteroplasmy could result in 
changes in the relative ratios of the two genomes upon cell division.  The presence of 
heteroplasmic condition in a transgenic plant might retrograde back to the wildtype 
eliminating the transgene in the absence of selection pressure in subsequent generations.  
The chimeric, aminoglycoside 3’ adenyltransferase (aadA) gene, conferring resistance to 
spectinomycin was used as a selectable marker and its expression is driven by the 16S 
(Prrn) promoter (Daniell et al., 2001a, Svab and Maliga, 1993).  Spectinomycin binds the 
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70S ribosome and inhibits translocation of peptidal tRNAs from the A site to the P site 
during protein synthesis.  The aadA gene codes for the enzyme aminoglycoside 3’ 
adenyltransferase, which transfers the adenyl moiety of ATP to spectinomycin, 
inactivating it.  The pLD-5’UTR-His-PA83/PA63 vector has a functional chloroplast 
origin of replication, which increases the number of templates for integration into the 
chloroplast genome (Daniell et al., 2004d).  Fourth, expression can depend on source of 
the gene and its' relative AT/GC content.  The prokaryotic-like chloroplast favors AT-
rich sequences, which reflects the respective tRNA abundance. Therefore the PA 
bacterial gene having 67% AT are expected to express well in the chloroplast. High 
expression of synthetic Human Somatotropin (HST), human serum albumin, human 
interferon-α2b, Human interferon-γ, Insulin like growth factor shows that eukaryotic 
genes can also be expressed in the plastid (Staub et al., 2000, Fernandez et al., 2003, 
Daniell et al., 2004c, Leelavathi and Reddy, 2003, Daniell, 2004) however; some 
eukaryotic genes need to be optimized for chloroplast expression. Genetic engineering of 
the chloroplast genome to express the PA83/63 with His tag served two purposes, that is 
to achieve high expression of the foreign protein and for gene containment. The use of 
the psbA-5’UTR has been shown to be vital in achieving hyper expression of several 
proteins in the chloroplast. The psbA gene encodes for the 32 kDa D1 protein, which is an 
integral part of Photosystem II. It has been shown that the initiation of psbA mRNA 
translation in tobacco is light regulated by sequences outside of the coding region (Staub 
and Maliga, et al., 1994, Fernandez et al.,2003, Dhingra et al.,2004, Watson et al., 2004).  
The 3’UTR region of the psbA gene present in the transgene cassette confers transcript 
stability.  Using mutants generated by sequence deletion and base alteration, it has been 
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recently demonstrated that the correct primary sequence and secondary structure of the 
psbA 5’UTR are required for mRNA stabilization and translation (Zou et al., 2003).The 
expression levels in plant leaves expressing PA83 with Histag on day 0 (4.78% in mature 
leaves) is relatively high compared to PA63 with Histag on day 0 (0.8% in mature 
leaves). There is a difference in the expression levels between the two constructs. 
Besides, though the plants expressing PA63 showed flowering, they did not produce 
seeds. So the plants expressing PA83 only were passed on for the continuous light 
studies. While PA63 expressing plants were allowed to grow under regular light pattern 
for them to produce the seeds. Seeds were never produced even after several months. The 
light-regulated 5'UTR from psbA gene, including its promoter, was used to enhance 
transcription and translation of PA.   The light-regulated psbA-5’UTR therefore accounts 
for both the high expression of PA and the change in expression over 5 days of 
continuous illumination.  The highest percentage of PA83 with his tag in Total Soluble 
Protein (%TSP) peaked in the mature leaves in day five (14.17%). Percent TSP values 
depend on the accumulation of all the proteins in the plants cell. By day seven of 
continuous illumination, plants appeared stressed, having decreased green pigmentation.  
Interruption of light dark periods therefore probably caused up-regulation of some stress-
induced proteins and down-regulation of photosynthetic proteins as well as the PA 
transgene driven by the psbA-5’UTR. Protein isolation and purification from plants is 
difficult task, owing to the complexity of the plant system compared to bacterial or yeast 
systems (Desai et al., 2002). The better yield of the desired protein can be obtained by 
reducing the purification steps. Current purification techniques for plant proteins involve 
a series of low-efficiency purification steps, which include several ion-exchange and gel-
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filtration chromatography columns. With each step the yield of target protein is reduced 
and the manufacturing costs are increased. It is well established that affinity 
chromatography is a powerful purification method that can reduce the number of steps 
and increase the purity of the isolated protein. It takes advantage of the highly specific 
binding affinity of the target protein toward an immobilized ligand (Hentz et al., 
1996).The His tag present at the N-terminal end of PA 83 aided in purifying the PA83. 
Affinity chromatography with resin column carrying Nickel ions binds to the 6X-
Histidine chain present N-terminal to PA83. The non specific plant proteins are washed 
away followed by the elution with gradient of 0.5 M Imidazole. The purified protein was 
detected in the fractions using ELISA. The functionality of the PA83 with Histag was 
analysed invitro using macrophage lysis assay. The chloroplast derived purified PA is 
functionally similar to PA83 derived from Bacillus anthracis. The PA83 was cleaved by 
the furin proteases and the PA63 fragment was able to bind to LF, be internalized and 
lyse the macrophage cells. The mouse macrophage lysis assay showed that there is atleast 
20ug/ml of functional PA. The Immunization experiments in mice showed that the PA83 
derived from chloroplast was functionally similar to PA derived from Bacillus anthracis 
in vivo. The anti-PA IgG antibody titers obtained in the group of mice injected with 
chloroplast derived PA83 is similar to that of produced in the mice group injected with 
PA83 derived from Bacillus anthracis. The antibody titers for the mice group injected 
with purified PA83 with adjuvant was four times higher than the group injected without 
adjuvant. The studies had clearly proved that the Chloroplast derived PA83 is 
functionally as good as PA83 derived from Bacillus anthracis. 
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Future studies 
Assessment of Immunoprotective properties of transgenic Plant-derived PA83 
The mice will have to be tested for the immunoprotective properties. For this the 
mice will be challenged with lethal toxin of Bacillus anthracis. The survival percentage 
will be evaluated and immunoprotective properties will be determined.  
Development of oral delivery immunization protocol 
Optimized protocol for the oral delivery of PA will be designed to develop 
significant IgA mucosal immune response. 
Development of transgenic carrots expressing PA83 
Development of transgenic carrot expressing PA83 will open the door for the oral 
delivery of the vaccine and develop mucosal immune response. An ideal vaccine for 
Bacillus anthracis should induce both mucosal and systemic protection.  If both 
subcutaneous and oral prove to be immunoprotective, priming both the mucosal and 
systemic systems may prove not only to be the cheapest way but also the most 
immunoprotective way of vaccination against any pathogen that attacks both the mucosal 





The PA83 expressed in transgenic tobacco proved to be functionally similar to PA 
derived from Bacillus anthracis. The comparable IgG levels in mice groups immunized 
with chloroplast derived purified PA83 and PA should eliminate the concerns regarding 
the protein folding and assembly. There are several reasons that make genetic 
engineering of the chloroplast genome the most cost effective and prudent way to 
produce the PA83 recombinant protein for use as a vaccine. Maternal inheritance allows 
for gene containment.  The technology exists to harvest and store plant produced proteins 
making the cost of production of recombinant proteins in tobacco leaves up to 10 to 50 
times cheaper than that of E. coli fermentation (with 20% expression levels in E. coli, 
Kusnadi et al., 1997).   
 PCR and Southern analysis confirmed the PA transgene to be present in the 
tobacco chloroplast genome.  Immunoblot analysis confirmed the expression of 83 kDa / 
63kDa PA protein.  ELISA showed PA expression levels up to 14.78% total soluble 
protein. The in vitro and in vivo experiments prove that the PA83 is biologically 
functional similar to PA derived from Bacillus antharcis. The immunization studies 
showed that the chloroplast derived PA83 and PA83 derived from Bacillus anthracis 
elicited comparable immune responses and that the plant derived PA83 is biologically 
functionally similar to that of PA83 derived from Bacillus antharcis.  
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